| EOS-AX7463 | Diphenyleneiodonium chloride | 4673-26-1 | C12H8ClI | 314.55 | C12C(CCCC3)C3[I+]C1CCCC2.[Cl-] |
| EOS-AX7464 | Dihydroergotoxine mesylate | 8067-24-1 | C20H29N3O5S | 423.53 | C[C@@](/N=C(O)/[C@](C1)([H])C[C@]2([H])C3=C4C(C[C@@]2([H])N1C)=CNC4=CC=C3)([H])CO.CS(O)(=O)=O |
| EOS-AX7465 | Dimaprit dihydrochloride | 23256-33-9 | C6H15N3S.2HCl | 234.19 | NC(SCCCN(C)C)=N.Cl.Cl |
| EOS-AX7466 | Dantrolene, sodium salt | 14663-23-1 | C14H9N4NaO5 | 336.23 | O=C1N=C(N(C1)/N=C/C2=CC=C(C(C=C3)=CC=C3[N+]([O-])=O)O2)[O-].[Na+] |
| EOS-AX7467 | BD 1008 dihydrobromide | 138356-09-9 | C15H22Cl2N2.2HBr | 463.08 | ClC1=CC(CCN(C)CCN2CCCC2)=CC=C1Cl.Br.Br |
| EOS-AX7468 | SKF 91488 dihydrochloride | 68941-21-9 | C7H17N3S.2HCl | 248.21 | CN(CCCCSC(N)=N)C.Cl.Cl |
| EOS-AX7469 | GBR 12783 dihydrochloride | 67469-75-4 | C28H32N2O.2HCl | 485.5 | [H]/C(CN1CCN(CCOC(C2=CC=CC=C2)C3=CC=CC=C3)CC1)=C([H])\C4=CC=CC=C4.Cl.Cl |
| EOS-AX7470 | EBPC | 4450-98-0 | C14H15NO4 | 261.28 | OC1=C(C(OCC)=O)CN(C1=O)CC2=CC=CC=C2 |
| EOS-AX7471 | 4F 4PP oxalate | 144734-36-1 | C22H26FNO.C2H2O4 | 429.49 | FC1=CC=C(C=C1)C(C2CCN(CCCCC3=CC=CC=C3)CC2)=O.OC(C(O)=O)=O |
| EOS-AX7472 | AMI-193 | 510-74-7 | C22H26FN3O2 | 383.46 | FC1=CC=C(C=C1)OCCCN2CC[C@]3(CC2)N(C4=CC=CC=C4)CNC3=O |
| EOS-AX7473 | (±)-Hexanoylcarnitine chloride | 6920-35-0 | C13H26ClNO4 | 295.81 | OC(C[C@H](C[N+](C)(C)C)OC(CCCCC)=O)=O.[Cl-] |
| EOS-AX7474 | 8-Hydroxy-DPAT hydrobromide | 76135-31-4 | C16H25NO.HBr | 328.29 | OC1=C2C[C@H](CCC2=CC=C1)N(CCC)CCC.Br |
| EOS-AX7475 | W-84 dibromide | 21093-51-6 | C32H44Br2N4O4 | 708.53 | O=C1N(C(C2=CC=CC=C12)=O)CCC[N+](C)(C)CCCCCC[N+](C)(C)CCCN(C3=O)C(C4=CC=CC=C34)=O.[Br-].[Br-] |
| EOS-AX7476 | HEAT hydrochloride | 30007-39-7 | C19H21NO2.HCl | 331.84 | O=C1[C@@H](C[NH2+]CCC(C=C2)=CC=C2O)CCC3=CC=CC=C13.[Cl-] |
| EOS-AX7477 | MR 16728 hydrochloride | 207403-36-9 | C23H36N2O.HCl | 393.01 | O/C(C(C1CCCCC1)C2=CC=CC=C2)=N\CCCN3CCCCCC3.Cl |
| EOS-AX7478 | trans-4-Hydroxycrotonic acid | 24587-49-3 | C4H6O3 | 102.09 | OC/C=C/C(O)=O |
| EOS-AX7479 | H-7 dihydrochloride | 108930-17-2 | C14H17N3O2S.2HCl | 364.29 | O=S(N1[C@H](C)CNCC1)(C2=CC=CC3=C2C=CN=C3)=O.Cl.Cl |
| EOS-AX7480 | C-1 | 84468-24-6 | C13H15N3O2S | 277.34 | O=S(N1CCNCC1)(C2=CC=CC3=C2C=CN=C3)=O |
| EOS-AX7481 | Ifenprodil hemitartrate | 23210-58-4 | C21H27NO2.½C4H6O6 | 400.49 | C[C@@](N1CCC(CC2=CC=CC=C2)CC1)([H])[C@@](O)([H])C3=CC=C(O)C=C3.C[C@@](N4CCC(CC5=CC=CC=C5)CC4)([H])[C@@](O)([H])C6=CC=C(O)C=C6.O[C@](C(O)=O)([H])[C@](O)([H])C(O)=O |
| EOS-AX7482 | L-NIO dihydrochloride | 159190-44-0 | C7H15N3O2.2HCl | 246.13 | OC([C@H](CCC/N=C(C)/N)N)=O.Cl.Cl |
| EOS-AX7483 | (±)-Lauroylcarnitine chloride | 7023-03-2 | C19H38NO4Cl | 379.97 | O=C(CCCCCCCCCCC)O[C@H](CC(O)=O)C[N+](C)(C)C.[Cl-] |
| EOS-AX7484 | Methylergometrine maleate | 57432-61-8 | C20H25N3O2.C4H4O4 | 455.51 | O=C([C@H]1CN(C)[C@H](CC2=CNC3=CC=CC4=C23)C4=C1)N[C@H](CO)CC.OC(/C=C\C(O)=O)=O |
| EOS-AX7485 | MMPX | 78033-08-6 | C12H18N4O3 | 266.3 | O=C(N(C)C1=O)N(C2=C1NC(COC)=N2)CC(C)C |
| EOS-AX7486 | NAN-190 hydrobromide | 115338-32-4 | C23H27N3O3.HBr | 474.4 | O=C(C1=CC=CC=C21)N(C2=O)CCCCN3CCN(C4=CC=CC=C4OC)CC3.Br |
| EOS-AX7487 | FG 7142 | 78538-74-6 | C13H11N3O | 225.25 | CNC(C1=NC=C2C(C3=CC=CC=C3N2)=C1)=O |
| EOS-AX7488 | BP 554 maleate | 82900-57-0 | C20H24N2O3.C4H4O4 | 456.48 | O=C(O)/C([H])=C([H])\C(O)=O.C1(N2CCN(CC2)CCCOC3=CC4=C(OCO4)C=C3)=CC=CC=C1 |
| EOS-AX7489 | α-Methyl-5-hydroxytryptamine maleate | 97469-12-0 | C11H14N2O.C4H4O4 | 306.32 | OC1=CC=C2NC=C(C2=C1)C[C@@H](C)N.OC(/C=C\C(O)=O)=O |
| EOS-AX7490 | N-Methylquipazine dimaleate | 171205-17-7 | C14H17N3.(C4H4O4)2 | 459.45 | OC(/C=C\C(O)=O)=O.OC(/C=C\C(O)=O)=O.CN1CCN(C2=NC3=CC=CC=C3C=C2)CC1 |
| EOS-AX7491 | (±)-Myristoylcarnitine chloride | 14919-38-1 | C21H42ClNO4 | 408.02 | O=C(CCCCCCCCCCCCC)O[C@H](CC(O)=O)C[N+](C)(C)C.[Cl-] |
| EOS-AX7492 | PCA 4248 | 123875-01-4 | C19H23NO4S | 361.46 | O=C(C1=C(C)NC(C)=C(C(OC)=O)[C@H]1C)OCCSC2=CC=CC=C2 |
| EOS-AX7493 | (S)-(+)-α-Methylhistamine dihydrobromide | 75614-93-6 | C6H11N3.2HBr | 287 | N[C@@H](C)CC1=CN=CN1.Br.Br |
| EOS-AX7494 | Nα-Methylhistamine dihydrochloride | 16503-22-3 | C6H11N3.2HCl | 198.09 | CNCCC1=CN=CN1.Cl.Cl |
| EOS-AX7495 | Methyl 2,5-dihydroxycinnamate | 63177-57-1 | C10H10O4 | 194.19 | OC(C(/C=C/C(OC)=O)=C1)=CC=C1O |
| EOS-AX7496 | Tyrphostin B44, (-) enantiomer | 133550-32-0 | C18H16N2O3 | 308.34 | O=C(/C(C#N)=C/C(C=C1O)=CC=C1O)N[C@H](C)C2=CC=CC=C2 |
| EOS-AX7497 | Tyrphostin B44, (+) enantiomer | 133550-37-5 | C18H16N2O3 | 308.34 | O=C(/C(C#N)=C\C(C=C1O)=CC=C1O)N[C@@H](C)C2=CC=CC=C2 |
| EOS-AX7498 | 3-MPPI | 133399-65-2 | C23H25N5O3 | 419.48 | O=C(C(NC1=CC=CC=C21)=C2NC3=O)N3CCN4CCN(C5=CC=CC=C5OC)CC4 |
| EOS-AX7499 | Methiothepin maleate | 19728-88-2 | C20H24N2S2.C4H4O4 | 472.62 | CN1CCN(CC1)[C@@H](C2=C3)CC4=CC=CC=C4SC2=CC=C3SC.OC(/C=C\C(O)=O)=O |
| EOS-AX7500 | 5-Methylfurmethiodide | 1197-60-0 | C9H16INO | 281.14 | C[N+](C)(C)CC1=CC=C(C)O1.[I-] |
| EOS-AX7501 | PRE-084 hydrochloride | 75136-54-8 | C19H27NO3.HCl | 353.89 | O=C(C1(C2=CC=CC=C2)CCCCC1)OCCN3CCOCC3.Cl |
| EOS-AX7502 | Metergoline | 17692-51-2 | C25H29N3O2 | 403.52 | O=C(NC[C@@H]1C[C@H]2[C@@H](CC3=CN(C)C4=CC=CC2=C34)N(C)C1)OCC5=CC=CC=C5 |
| EOS-AX7503 | Naloxonazine dihydrochloride | 880759-65-9 | C38H42N4O6.2HCl | 723.69 | O[C@@]([C@@H]1N(CC=C)CC2)(CC/C3=N/N=C4[C@H]([C@]5(C6=C(C=C7)C8)[C@]([C@@H]8N(CC=C)CC5)(CC/4)O)OC6=C7O)[C@@]2(C9=C(C=C%10)C1)[C@@H]3OC9=C%10O.Cl.Cl |
| EOS-AX7504 | NPPB | 107254-86-4 | C16H16N2O4 | 300.31 | OC(C1=CC([N+]([O-])=O)=CC=C1NCCCC2=CC=CC=C2)=O |
| EOS-AX7505 | SNAP | 79032-48-7 | C7H12N2O4S | 220.24 | OC([C@H](C(C)(C)SN=O)NC(C)=O)=O |
| EOS-AX7506 | 7-Nitroindazole | 2942-42-9 | C7H5N3O2 | 163.14 | [O-][N+](C1=C2NN=CC2=CC=C1)=O |
| EOS-AX7507 | SNOG | 57564-91-7 | C10H16N4O7S | 336.32 | O=C(CC[C@@H](C(O)=O)N)N[C@H](C(NCC(O)=O)=O)CSN=O |
| EOS-AX7508 | (±)-Octanoylcarnitine chloride | 18822-86-1 | C15H30ClNO4 | 323.86 | O=C(CCCCCCC)O[C@@H](CC(O)=O)C[N+](C)(C)C.[Cl-] |
| EOS-AX7509 | OBAA | 221632-26-4 | C28H44O3 | 428.65 | O=C(C(C(O)=O)=C)C1=CC(CCCCCCCCCCCCCCCCCC)=CC=C1 |
| EOS-AX7510 | 17-ODYA | 34450-18-5 | C18H32O2 | 280.45 | OC(CCCCCCCCCCCCCCCC#C)=O |
| EOS-AX7511 | (±)-Palmitoylcarnitine chloride | 6865-14-1 | C23H46ClNO4 | 436.07 | O=C(CCCCCCCCCCCCCCC)O[C@@H](CC(O)=O)C[N+](C)(C)C.[Cl-] |
| EOS-AX7512 | (±)-Propionylcarnitine chloride | 18828-58-5 | C10H20ClNO4 | 253.73 | OC(C[C@H](C[N+](C)(C)C)OC(CC)=O)=O.[Cl-] |
| EOS-AX7513 | AG 556 | 133550-41-1 | C20H20N2O3 | 336.39 | O=C(/C(C#N)=C/C(C=C1O)=CC=C1O)NCCCCC2=CC=CC=C2 |
| EOS-AX7514 | AG 555 | 133550-34-2 | C19H18N2O3 | 322.36 | O=C(/C(C#N)=C/C(C=C1O)=CC=C1O)NCCCC2=CC=CC=C2 |
| EOS-AX7515 | AG 494 | 133550-35-3 | C16H12N2O3 | 280.28 | OC1=CC(/C=C(C#N)/C(NC2=CC=CC=C2)=O)=CC=C1O |
| EOS-AX7516 | 4-PPBP maleate | 201216-39-9 | C21H27N.C4H4O4 | 409.52 | OC(/C=C/C(O)=O)=O.N1(CCCCC2=CC=CC=C2)CCC(C3=CC=CC=C3)CC1 |
| EOS-AX7517 | Physostigmine hemisulfate | 64-47-1 | C15H21N3O2.1/2H2SO4 | 324.39 | C[C@](C1=C2C=CC(O/C(O)=N/C)=C1)([C@@]3([H])N2C)CCN3C.C[C@](C4=C5C=CC(O/C(O)=N/C)=C4)([C@@]6([H])N5C)CCN6C.OS(O)(=O)=O |
| EOS-AX7518 | PPADS tetrasodium salt | 192575-19-2 | C14H10N3Na4O12PS2 | 599.3 | [O-]S(=O)(C1=CC(S([O-])(=O)=O)=CC=C1N/N=C(C(COP([O-])([O-])=O)=C2C=O)\N=C(C)C2=O)=O.[Na+].[Na+].[Na+].[Na+] |
| EOS-AX7519 | 2-PMDQ | 139047-55-5 | C21H23N5O | 361.45 | O=C1N2C[C@@H](CN3CCN(C4=CC=CC=C4)CC3)N=C2C5=CC=CC=C5N1 |
| EOS-AX7520 | Quipazine dimaleate | 150323-78-7 | C13H15N3.2C4H4O4 | 445.43 | OC(/C=C\C(O)=O)=O.OC(/C=C\C(O)=O)=O.N1(C2=NC3=CC=CC=C3C=C2)CCNCC1 |
| EOS-AX7521 | Spiroxatrine | 1054-88-2 | C22H25N3O3 | 379.46 | O=C1NCN(C2=CC=CC=C2)[C@]31CCN(C[C@H]4OC5=CC=CC=C5OC4)CC3 |
| EOS-AX7522 | D-erythro-Sphingosine (synthetic) | 123-78-4 | C18H37NO2 | 299.5 | O[C@H](/C=C/CCCCCCCCCCCCC)[C@H](CO)N |
| EOS-AX7523 | Synthalin sulfate | 182285-12-7 | C12H28N6.H2SO4 | 354.47 | OS(O)(=O)=O.N/C(N)=N\CCCCCCCCCC/N=C(N)\N |
| EOS-AX7524 | Salsolinol-1-carboxylic acid | 57256-34-5 | C11H13NO4 | 223.23 | OC([C@@](C1=C2)(C)NCCC1=CC(O)=C2O)=O |
| EOS-AX7525 | CGS 12066B dimaleate | 109028-10-6 | C17H17F3N4.2C4H4O4 | 566.49 | FC(F)(C1=CC=C2N3C(C(N4CCN(C)CC4)=NC2=C1)=CC=C3)F.OC(/C=C/C(O)=O)=O.OC(/C=C/C(O)=O)=O |
| EOS-AX7526 | MDL 72222 | 40796-97-2 | C15H17Cl2NO2 | 314.21 | ClC1=CC(Cl)=CC(C(O[C@H]2C[C@H]3N(C)[C@@H](C2)CC3)=O)=C1 |
| EOS-AX7527 | Thioperamide | 106243-16-7 | C15H24N4S | 292.44 | S=C(NC1CCCCC1)N2CCC(C3=CN=CN3)CC2 |
| EOS-AX7528 | 2-TEDC | 132465-10-2 | C16H13NO4S | 315.34 | OC1=CC(/C=C(C#N)/C(OCCC2=CC=CS2)=O)=CC=C1O |
| EOS-AX7529 | HTMT dimaleate | 195867-54-0 | C19H25F3N4O.2C4H4O4 | 614.57 | CC(NCCC1=CN=CN1)CCCCC(NC2=CC=C(C(F)(F)F)C=C2)=O.O=C(O)/C([H])=C([H])\C(O)=O.O=C(O)/C([H])=C([H])\C(O)=O |
| EOS-AX7530 | (±)-Vesamicol hydrochloride | 120447-62-3 | C17H25NO.HCl | 295.85 | O[C@H]1[C@@H](CCCC1)N2CCC(C3=CC=CC=C3)CC2.Cl |
| EOS-AX7531 | FGIN-1-27 | 142720-24-9 | C28H37FN2O | 436.61 | FC1=CC=C(C=C1)C(NC2=CC=CC=C32)=C3CC(N(CCCCCC)CCCCCC)=O |
| EOS-AX7532 | FGIN-1-43 | 145040-29-5 | C28H36Cl2N2O | 487.51 | ClC1=CC=C2NC(C(C=C3)=CC=C3Cl)=C(C2=C1)CC(N(CCCCCC)CCCCCC)=O |
| EOS-AX7533 | Mepyramine maleate | 59-33-6 | C17H23N3O.C4H4O4 | 401.46 | CN(C)CCN(C1=NC=CC=C1)CC(C=C2)=CC=C2OC.OC(/C=C\C(O)=O)=O |
| EOS-AX7534 | 2-MPMDQ | 149847-77-8 | C23H27N5O2 | 405.5 | O=C1N2C[C@@H](CN3CCN(C4=CC=CC=C4OC)CC3)N=C2C5=CC=CC=C5N1C |
| EOS-AX7535 | trans-Triprolidine hydrochloride | 550-70-9 | C19H22N2.HCl | 314.86 | CC1=CC=C(C=C1)/C(C2=NC=CC=C2)=C/CN3CCCC3.Cl |
| EOS-AX7536 | 3-AQC | 201216-42-4 | C16H17N5.C4H4O4 | 395.42 | OC(/C=C/C(O)=O)=O.N#CC1=NC2=CC=CC=C2N=C1N3CCN(CC=C)CC3 |
| EOS-AX7537 | Amthamine dihydrobromide | 142457-00-9 | C6H11N3S.2HBr | 319.06 | NCCC1=C(C)N=C(N)S1.Br.Br |
| EOS-AX7538 | PK 11195 | 85532-75-8 | C21H21ClN2O | 352.86 | ClC1=CC=CC=C1C2=C(C=CC=C3)C3=CC(C(N(C)[C@H](C)CC)=O)=N2 |
| EOS-AX7539 | L-Canavanine sulfate | 2219-31-0 | C5H12N4O3.H2SO4 | 274.25 | OS(O)(=O)=O.OC([C@H](CCO/N=C(N)\N)N)=O |
| EOS-AX7540 | (+)-AJ 76 hydrochloride | 85379-09-5 | C15H23NO.HCl | 269.81 | CCCN[C@]1([H])CCC2=C([C@]1([H])C)C=CC=C2OC.Cl |
| EOS-AX7541 | 2-Phenylmelatonin | 151889-03-1 | C19H20N2O2 | 308.38 | O=C(C)NCCC(C1=C2)=C(C3=CC=CC=C3)NC1=CC=C2OC |
| EOS-AX7542 | iso-PPADS tetrasodium salt | 207572-67-6 | C14H10N3Na4O12PS2 | 599.3 | [O-]S(=O)(C(C(N/N=C(C(COP([O-])([O-])=O)=C1C=O)\N=C(C)C1=O)=C2)=CC=C2S([O-])(=O)=O)=O.[Na+].[Na+].[Na+].[Na+] |
| EOS-AX7543 | (±)-Epibatidine | 148152-66-3 | C11H13ClN2 | 208.69 | ClC(N=C1)=CC=C1[C@H]2[C@H](CC3)N[C@H]3C2 |
| EOS-AX7544 | BRL 52537 hydrochloride | 112282-24-3 | C18H24Cl2N2O.HCl | 391.77 | ClC1=C(Cl)C=C(CC(N2CCCCC2CN3CCCC3)=O)C=C1.Cl |
| EOS-AX7545 | 3'-Fluorobenzylspiperone maleate | 1135278-61-3 | C30H31F2N3O2.C4H4O4 | 619.67 | FC1=CC(CN2C([C@]3(CCN(CCCC(C(C=C4)=CC=C4F)=O)CC3)N(C5=CC=CC=C5)C2)=O)=CC=C1.OC(/C=C\C(O)=O)=O |
| EOS-AX7546 | BTCP maleate | 207455-25-2 | C19H25NS.C4H4O4 | 415.55 | OC(/C=C\C(O)=O)=O.N1(CCCCC1)C2(C3=CC4=CC=CC=C4S3)CCCCC2 |
| EOS-AX7547 | Anpirtoline hydrochloride | 99201-87-3 | C10H13ClN2S.HCl | 265.2 | ClC1=CC=CC(SC2CCNCC2)=N1.Cl |
| EOS-AX7548 | L-701,252 | 151057-13-5 | C13H10ClNO3 | 263.68 | ClC1=CC=C2C(O)=C(C(NC2=C1)=O)C(C3CC3)=O |
| EOS-AX7549 | 7-Hydroxy-DPAT hydrobromide | 76135-30-3 | C16H25NO.HBr | 328.28 | OC1=CC=C2CC[C@@H](CC2=C1)N(CCC)CCC.Br |
| EOS-AX7550 | 2-Hydroxypropyl-β-cyclodextrin | 128446-35-5 | (C6H9O5)7(C3H7O)n | 1400 | |
| EOS-AX7551 | MAP4 | 157381-42-5 | C5H12NO5P | 197.13 | OP(O)(CC[C@@](C)(C(O)=O)N)=O |
| EOS-AX7552 | Cyclothiazide | 2259-96-3 | C14H16ClN3O4S2 | 389.87 | ClC(C=C1N[C@@H]([C@@H]2[C@H](C=C3)C[C@H]3C2)NS(=O)(C1=C4)=O)=C4S(=O)(N)=O |
| EOS-AX7553 | 7-Hydroxy-PIPAT maleate | 159559-71-4 | C16H22INO.C4H4O4 | 487.33 | CCCN(C1CCC2=CC=C(O)C=C2C1)C/C([H])=C([H])/I.O=C(O)/C([H])=C([H])\C(O)=O |
| EOS-AX7554 | Aminopotentidine | 140873-26-3 | C26H35N7O2 | 477.6 | O=C(C(C=C1)=CC=C1N)NCCN/C(NC#N)=N/CCCOC2=CC(CN3CCCCC3)=CC=C2 |
| EOS-AX7555 | N-Acetyl-N-acetoxy-4-chlorobenzenesulfonamide | 142867-52-5 | C10H10ClNO5S | 291.71 | ClC1=CC=C(C=C1)S(=O)(N(C(C)=O)OC(C)=O)=O |
| EOS-AX7556 | Tetrindole mesylate | 170964-68-8 | C20H26N2.CH3SO3H | 390.54 | CS(O)(=O)=O.C1(C2=CC(C3=C4C(NCCN54)CCC3)=C5C=C2)CCCCC1 |
| EOS-AX7557 | Pirlindole mesylate | 207572-66-5 | C15H18N2.CH3SO3H | 322.42 | OS(=O)(C)=O.CC1=CC=C2N3C4=C(C2=C1)CCC[C@H]4NCC3 |
| EOS-AX7558 | BU 224 hydrochloride | 205437-64-5 | C12H11N3.HCl | 233.7 | C12=CC=CC=C1N=C(C3=NCCN3)C=C2.Cl |
| EOS-AX7559 | Pyrrolidinedithiocarbamate ammonium | 5108-96-3 | C5H12N2S2 | 164.28 | [S-]C(N1CCCC1)=S.[NH4+] |
| EOS-AX7560 | RS 23597-190 hydrochloride | 149719-06-2 | C16H23ClN2O3.HCl | 363.28 | ClC(C=C(C(OC)=C1)C(OCCCN2CCCCC2)=O)=C1N.Cl |
| EOS-AX7561 | Imetit dihydrobromide | 32385-58-3 | C6H10N4S.2HBr | 332.06 | NC(SCCC1=CN=CN1)=N.Br.Br |
| EOS-AX7562 | 4-Phenyl-1,2,3,4-tetrahydroisoquinoline hydrochloride | 6109-35-9 | C15H15N.HCl | 245.75 | [C@H]1(C2=CC=CC=C2)CNCC3=CC=CC=C13.Cl |
| EOS-AX7563 | 3-Bromo-7-nitroindazole | 74209-34-0 | C7H4BrN3O2 | 242.03 | BrC1=C2C(C([N+]([O-])=O)=CC=C2)=NN1 |
| EOS-AX7564 | 2-[1-(4-Piperonyl)piperazinyl]benzothiazole | 155106-73-3 | C19H19N3O2S | 353.44 | N1(CC2=CC=C3OCOC3=C2)CCN(C4=NC5=CC=CC=C5S4)CC1 |
| EOS-AX7565 | 2-Iodomelatonin | 93515-00-5 | C13H15IN2O2 | 358.18 | IC1=C(CCNC(C)=O)C2=CC(OC)=CC=C2N1 |
| EOS-AX7566 | Naltrindole hydrochloride | 111469-81-9 | C26H26N2O3.HCl | 450.96 | O[C@]([C@@H]1N(CC2CC2)CC3)(CC4=C5NC6=CC=CC=C46)[C@@]3(C7=C(C=C8)C1)[C@H]5OC7=C8O.Cl |
| EOS-AX7567 | L-689,560 | 139051-78-8 | C17H15Cl2N3O3 | 380.23 | ClC1=C2[C@H](C[C@@H](C(O)=O)NC2=CC(Cl)=C1)NC(NC3=CC=CC=C3)=O |
| EOS-AX7568 | Zinc protoporphyrin IX | 15442-64-5 | C34H32N4O4Zn | 626.03 | OC(CCC1=C(C)/C([N-]/C1=C\2)=C/C(C(C)=C/3C=C)=NC3=C/C4=N/C(C(C=C)=C4C)=C\C5=C(C)C(CCC(O)=O)=C2[N-]5)=O.[Zn+2] |
| EOS-AX7569 | Tin protoporphyrin IX dichloride | 14325-05-4 | C34H32Cl2N4O4Sn | 750.25 | C=CC1=C(/C2=C([H])/C(C(C)=C/3CCC([O-])=O)=NC3=C([H])/C4=N/C(C(C)=C4CCC([O-])=O)=C([H])\C5=C(C(C)=C([N-]5)/C([H])=C1\[N-]2)C=C)C.Cl.Cl.[Sn+4] |
| EOS-AX7570 | 4-IBP | 155798-08-6 | C19H21IN2O | 420.29 | IC1=CC=C(C=C1)C(NC2CCN(CC3=CC=CC=C3)CC2)=O |
| EOS-AX7571 | Dihydrosphingosine | 3102-56-5 | C18H39NO2 | 301.51 | O[C@H]([C@H](CO)N)CCCCCCCCCCCCCCC |
| EOS-AX7572 | PG-9 maleate | 155649-00-6 | C17H22BrNO2.C4H4O4 | 468.34 | CC(C(O[C@]1([H])C[C@](N2C)([H])CC[C@]2([H])C1)=O)([H])C3=CC=C(Br)C=C3.O=C(O)/C([H])=C([H])\C(O)=O |
| EOS-AX7573 | SM-21 maleate | 155059-42-0 | C18H24ClNO3.C4H4O4 | 453.92 | ClC(C=C1)=CC=C1O[C@H](CC)C(O[C@@H]2C[C@@H]3N(C)[C@H](C2)CC3)=O.OC(/C=C/C(O)=O)=O |
| EOS-AX7574 | Clobenpropit dihydrobromide | 145231-35-2 | C14H17ClN4S.2HBr | 470.65 | ClC1=CC=C(C=C1)C/N=C(N)\SCCCC2=CN=CN2.Br.Br |
| EOS-AX7575 | N-Benzylnaltrindole hydrochloride | 1206487-81-1 | C33H32N2O3.HCl | 541.09 | OC1=C(O2)C3=C(C[C@]4([H])[C@]5(O)CC(C6=CC=CC=C6N7CC8=CC=CC=C8)=C7[C@@]2([H])[C@@]35CCN4CC9CC9)C=C1.Cl |
| EOS-AX7576 | Castanospermine | 79831-76-8 | C8H15NO4 | 189.21 | O[C@@H]([C@@H]1O)[C@@H]2N(C[C@@H]1O)CC[C@@H]2O |
| EOS-AX7577 | N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide | 155054-42-5 | C14H19IN2O | 358.22 | IC1=CC=C(C=C1)C(NCCN2CCCCC2)=O |
| EOS-AX7578 | SNC 80 | 156727-74-1 | C28H39N3O2 | 449.64 | O=C(C1=CC=C(C=C1)[C@H](C2=CC=CC(OC)=C2)N3[C@@H](C)CN(CC=C)[C@H](C)C3)N(CC)CC |
| EOS-AX7579 | Bifemelane hydrochloride | 62232-46-6 | C18H23NO.HCl | 305.84 | CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2.Cl |
| EOS-AX7580 | GBLD 345 | 122479-08-7 | C21H21N5O2 | 375.43 | COC1=CC=CC(C/N=C2C=CC3=NC(C4=CC=C(N)C=C4)=C(OC)N3N\2)=C1 |
| EOS-AX7581 | L-NMMA acetate | 53308-83-1 | C7H16N4O2.CH3CO2H | 248.28 | OC([C@H](CCCN/C(N)=N/C)N)=O.OC(C)=O |
| EOS-AX7582 | Carboxy-PTIO, potassium salt | 148819-94-7 | C14H16KN2O4 | 315.38 | CC(C1(C)C)(N(=C(N1[O])C2=CC=C(C([O-])=O)C=C2)=O)C.[K+] |
| EOS-AX7583 | (+)-UH 232 maleate | 95999-12-5 | C18H29NO.C4H4O4 | 391.51 | CCCN([C@]1([H])CCC2=C([C@]1([H])C)C=CC=C2OC)CCC.O=C(O)/C([H])=C([H])\C(O)=O |
| EOS-AX7584 | (S)-Methylisothiourea sulfate | 867-44-7 | C4H14N4O4S3 | 278.36 | NC(SC)=N.NC(SC)=N.OS(O)(=O)=O |
| EOS-AX7585 | ICI 199,441 hydrochloride | 115199-84-3 | C21H24Cl2N2O.HCl | 427.8 | ClC1=CC(CC(N(C)[C@@H](C2=CC=CC=C2)CN3CCCC3)=O)=CC=C1Cl.Cl |
| EOS-AX7586 | Iodophenpropit dihydrobromide | 145196-87-8 | C15H19IN4S.2HBr | 576.13 | IC1=CC=C(C=C1)CC/N=C(N)\SCCCC2=CN=CN2.Br.Br |
| EOS-AX7587 | NCS-382 | 520505-01-5 | C13H14O3 | 218.25 | O[C@@H]1C2=CC=CC=C2CCC/C1=C\C(O)=O |
| EOS-AX7588 | L-694,247 | 137403-12-4 | C20H21N5O3S | 411.48 | |
| EOS-AX7589 | Aminoguanidine hydrochloride | 1937-19-5 | CH6N4.HCl | 110.55 | N/C(N)=N\N.Cl |
| EOS-AX7590 | (±)-Anatoxin A fumarate | 1219922-30-1 | C10H15NO.C4H4O4 | 281.31 | CC(C1=CCC[C@]2([H])CC[C@@]1([H])N2)=O.O=C(O)/C([H])=C([H])/C(O)=O |
| EOS-AX7591 | Efaroxan hydrochloride | 89197-00-2 | C13H16N2O.HCl | 252.74 | CC[C@@]1(C2=NCCN2)OC3=CC=CC=C3C1.Cl |
| EOS-AX7592 | Idazoxan hydrochloride | 79944-56-2 | C11H12N2O2.HCl | 240.69 | [C@@H]1(C2=NCCN2)OC3=CC=CC=C3OC1.Cl |
| EOS-AX7593 | DIPPA hydrochloride | 155512-52-0 | C22H23Cl2N3OS.HCl | 484.87 | ClC1=CC(CC(N(C)[C@@H](C2=CC=CC(N=C=S)=C2)CN3CCCC3)=O)=CC=C1Cl.Cl |
| EOS-AX7594 | 8-Hydroxy-PIPAT oxalate | 159651-91-9 | C16H22INO.C2H2O4 | 461.3 | CCCN(C1CCC(C=CC=C2O)=C2C1)C/C([H])=C([H])/I.OC(C(O)=O)=O |
| EOS-AX7595 | MSOP | 66515-29-5 | C4H10NO6P | 199.1 | OC([C@](COP(O)(O)=O)(C)N)=O |
| EOS-AX7596 | (S)-3,5-DHPG | 162870-29-3 | C8H9NO4 | 183.16 | OC1=CC(O)=CC([C@@H](C(O)=O)N)=C1 |
| EOS-AX7597 | THIP hydrochloride | 85118-33-8 | C6H8N2O2.HCl | 176.6 | O=C1NOC2=C1CCNC2.Cl |
| EOS-AX7598 | (±)-threo-3-Methylglutamic acid | 63088-04-0 | C6H11NO4 | 161.16 | OC([C@H]([C@H](C)CC(O)=O)N)=O |
| EOS-AX7599 | (2R,3S)-Chlorpheg | 140924-23-8 | C11H12ClNO4 | 257.67 | ClC1=CC=C(C=C1)[C@H](CC(O)=O)[C@H](C(O)=O)N |
| EOS-AX7600 | ICI 204,448 hydrochloride | 121264-04-8 | C23H26Cl2N2O4.HCl | 501.84 | ClC1=CC(CC(N(C)[C@@H](C2=CC=CC(OCC(O)=O)=C2)CN3CCCC3)=O)=CC=C1Cl.Cl |
| EOS-AX7601 | ICI 89406 | 53671-71-9 | C19H22N4O3 | 354.41 | O[C@H](COC1=CC=CC=C1C#N)CNCCNC(NC2=CC=CC=C2)=O |
| EOS-AX7602 | ICI 162,846 | 84545-30-2 | C11H17F3N6O | 306.29 | FC(F)(C/N=C(N)/NC1=NN(C=C1)CCCCC(N)=O)F |
| EOS-AX7603 | (S)-(-)-Propranolol hydrochloride | 4199-10-4 | C16H21NO2.HCl | 295.81 | O[C@H](COC1=CC=CC2=CC=CC=C12)CNC(C)C.Cl |
| EOS-AX7604 | (R)-(+)-Propranolol hydrochloride | 13071-11-9 | C16H21NO2.HCl | 295.81 | O[C@@H](COC1=CC=CC2=CC=CC=C12)CNC(C)C.Cl |
| EOS-AX7605 | DHBP dibromide | 6159-05-3 | C24H38Br2N2 | 514.39 | CCCCCCC[N+](C=C1)=CC=C1C2=CC=[N+](C=C2)CCCCCCC.[Br-].[Br-] |
| EOS-AX7606 | DTG | 97-39-2 | C15H17N3 | 239.32 | N/C(NC1=CC=CC=C1C)=N\C2=CC=CC=C2C |
| EOS-AX7607 | Agmatine sulfate | 2482-00-0 | C5H14N4.H2SO4 | 228.27 | OS(O)(=O)=O.NCCCC/N=C(N)/N |
| EOS-AX7608 | Oxotremorine sesquifumarate | 17360-35-9 | C12H18N2O.1.5C4H4O4 | 380.4 | O=C1CCCN1CC#CCN2CCCC2.O=C3CCCN3CC#CCN4CCCC4.O=C(O)/C([H])=C([H])/C(O)=O.O=C(O)/C([H])=C([H])/C(O)=O.O=C(O)/C([H])=C([H])/C(O)=O |
| EOS-AX7609 | Evans Blue tetrasodium salt | 314-13-6 | C34H24N6Na4O14S4 | 960.82 | O=C1C(C(C=C/C1=N/NC(C(C)=C2)=CC=C2C3=CC=C(C(C)=C3)N/N=C4C(C(C(C=C\4)=C5S([O-])(=O)=O)=C(C(S([O-])(=O)=O)=C5)N)=O)=C6S([O-])(=O)=O)=C(C(S([O-])(=O)=O)=C6)N.[Na+].[Na+].[Na+].[Na+] |
| EOS-AX7610 | Chicago Sky Blue 6B | 2610-05-1 | C34H24N6Na4O16S4 | 992.79 | O=C1C(C(C=C/C1=N/NC(C(OC)=C2)=CC=C2C3=CC=C(C(OC)=C3)N/N=C4C(C(C(C=C\4)=C5S([O-])(=O)=O)=C(C(S([O-])(=O)=O)=C5)N)=O)=C6S([O-])(=O)=O)=C(C(S([O-])(=O)=O)=C6)N.[Na+].[Na+].[Na+].[Na+] |
| EOS-AX7611 | Propranolol glycol | 36112-95-5 | C13H14O3 | 218.25 | O[C@@H](CO)COC1=CC=CC2=CC=CC=C12 |
| EOS-AX7612 | MPPG | 169209-65-8 | C9H12NO5P | 245.17 | OC([C@@](C(C=C1)=CC=C1P(O)(O)=O)(C)N)=O |
| EOS-AX7613 | MSPG | 169209-64-7 | C9H11NO5S | 245.25 | OC([C@@](C(C=C1)=CC=C1S(O)(=O)=O)(C)N)=O |
| EOS-AX7614 | MTPG | 169209-66-9 | C10H11N5O2 | 233.23 | OC([C@](C(C=C1)=CC=C1N2N=NN=C2)(C)N)=O |
| EOS-AX7615 | L-732,138 | 148451-96-1 | C22H18F6N2O3 | 472.39 | FC(F)(C1=CC(C(F)(F)F)=CC(COC([C@H](CC2=CNC3=CC=CC=C23)NC(C)=O)=O)=C1)F |
| EOS-AX7616 | MDL 11,939 | 107703-78-6 | C20H25NO | 295.42 | O[C@H](C1=CC=CC=C1)C2CCN(CCC3=CC=CC=C3)CC2 |
| EOS-AX7617 | AMT hydrochloride | 21463-31-0 | C5H10N2S.HCl | 166.67 | NC1=NCC[C@@H](C)S1.Cl |
| EOS-AX7618 | EIT hydrobromide | 1071-37-0 | C3H8N2S.HBr | 185.08 | NC(SCC)=N.Br |
| EOS-AX7619 | AM 92016 hydrochloride | 133229-11-5 | C19H24Cl2N2O4S.HCl | 483.84 | CN(CC(O)COC1=CC=C(NS(C)(=O)=O)C=C1)CCC2=CC(Cl)=C(Cl)C=C2.Cl |
| EOS-AX7620 | Luzindole | 117946-91-5 | C19H20N2O | 292.38 | O=C(C)NCCC1=C(CC2=CC=CC=C2)NC3=CC=CC=C13 |
| EOS-AX7621 | Oleamide | 301-02-0 | C18H35NO | 281.48 | O=C(CCCCCCC/C=C\CCCCCCCC)N |
| EOS-AX7622 | Palmitoylethanolamide | 544-31-0 | C18H37NO2 | 299.5 | O=C(CCCCCCCCCCCCCCC)NCCO |
| EOS-AX7623 | ODQ | 41443-28-1 | C9H5N3O2 | 187.16 | O=C1ON=C2N1C3=CC=CC=C3N=C2 |
| EOS-AX7624 | Chlormethiazole hydrochloride | 6001-74-7 | C6H8ClNS.HCl | 198.11 | ClCCC1=C(C)N=CS1.Cl |
| EOS-AX7625 | ZM 226600 | 147695-92-9 | C16H14F3NO4S | 373.35 | FC(F)([C@](C(NC1=CC=C(C=C1)S(=O)(C2=CC=CC=C2)=O)=O)(C)O)F |
| EOS-AX7626 | BD 1063 dihydrochloride | 206996-13-6 | C13H18Cl2N2.2HCl | 346.13 | CN(CC1)CCN1CCC2=CC(Cl)=C(Cl)C=C2.Cl.Cl |
| EOS-AX7627 | Cirazoline hydrochloride | 40600-13-3 | C13H16N2O.HCl | 252.74 | C1(C2=CC=CC=C2OCC3=NCCN3)CC1.Cl |
| EOS-AX7628 | Rauwolscine hydrochloride | 6211-32-1 | C21H26N2O3.HCl | 390.91 | O[C@@H]1[C@@H](C(OC)=O)[C@@H]2[C@H](CC1)CN3[C@H](C(NC4=CC=CC=C54)=C5CC3)C2.Cl |
| EOS-AX7629 | (RS)-(±)-Sulpiride | 15676-16-1 | C15H23N3O4S | 341.42 | O=C(C(C=C1S(=O)(N)=O)=C(C=C1)OC)NC[C@@H]2N(CC)CCC2 |
| EOS-AX7630 | GR 135531 | 190277-13-5 | C14H17N3O3 | 275.31 | O=C(C)NCCC(C1=C2)=CNC1=CC=C2NC(OC)=O |
| EOS-AX7631 | S-Isopropylisothiourea hydrobromide | 4269-97-0 | C4H10N2S.HBr | 199.11 | NC(SC(C)C)=N.Br |
| EOS-AX7632 | BNTX maleate | 864461-31-4 | C27H27NO4.C4H4O4 | 545.59 | O[C@]1(C/C2=C\C3=CC=CC=C3)[C@]45CCN(CC6CC6)[C@@H]1CC(C=C7)=C4C(O[C@H]5C2=O)=C7O.OC(/C=C/C(O)=O)=O |
| EOS-AX7633 | 5-Nonyloxytryptamine oxalate | 157798-13-5 | C19H30N2O.C2H2O4 | 392.49 | CCCCCCCCCOC1=CC(C(CCN)=CN2)=C2C=C1.OC(C(O)=O)=O |
| EOS-AX7634 | SYM 2081 | 31137-74-3 | C6H11NO4 | 161.16 | C[C@](C(O)=O)([H])C[C@@](N)([H])C(O)=O |
| EOS-AX7635 | AIDA | 168560-79-0 | C11H11NO4 | 221.21 | OC([C@@]1(CCC2=CC(C(O)=O)=CC=C12)N)=O |
| EOS-AX7636 | L-701,324 | 142326-59-8 | C21H14ClNO3 | 363.8 | ClC1=CC=C2C(NC(C(C3=CC=CC(OC4=CC=CC=C4)=C3)=C2O)=O)=C1 |
| EOS-AX7637 | Cilostamide | 68550-75-4 | C20H26N2O3 | 342.44 | O=C(CCCOC1=CC=C(C(C=C2)=C1)NC2=O)N(C)C3CCCCC3 |
| EOS-AX7638 | Remoxipride hydrochloride | 73220-03-8 | C16H23BrN2O3.HCl | 407.73 | BrC1=C(C(C(NC[C@H]2N(CC)CCC2)=O)=C(C=C1)OC)OC.Cl |
| EOS-AX7639 | 3-CPMT | 14008-79-8 | C21H24ClNO.HCl | 378.34 | ClC1=CC=C(C=C1)[C@@H](C2=CC=CC=C2)O[C@@H]3C[C@@H]4N(C)[C@H](C3)CC4.Cl |
| EOS-AX7640 | 3α-Bis-(4-fluorophenyl) methoxytropane hydrochloride | 202646-03-5 | C21H23F2NO.HCl | 379.88 | CN1[C@@]2([H])CC[C@]1([H])C[C@@](OC(C3=CC=C(F)C=C3)C4=CC=C(F)C=C4)([H])C2.Cl |
| EOS-AX7641 | TRIM | 25371-96-4 | C10H7F3N2 | 212.17 | FC(F)(C1=CC=CC=C1N2C=CN=C2)F |
| EOS-AX7642 | SKF 38393 hydrobromide | 20012-10-6 | C16H17NO2.HBr | 336.23 | OC1=C(O)C=C2C(CCNCC2C3=CC=CC=C3)=C1.Br |
| EOS-AX7643 | SCH 23390 hydrochloride | 125941-87-9 | C17H18ClNO.HCl | 324.24 | ClC1=C(C=C2[C@@H](C3=CC=CC=C3)CN(C)CCC2=C1)O.Cl |
| EOS-AX7644 | β-Funaltrexamine hydrochloride | 72786-10-8 | C25H30N2O6.HCl | 490.99 | O[C@]([C@@H]1N(CC2CC2)CC3)(CC[C@H]4NC(/C=C/C(OC)=O)=O)[C@]3(C5=C(C=C6)C1)[C@H]4OC5=C6O.Cl |
| EOS-AX7645 | ARC 239 dihydrochloride | 55974-42-0 | C24H29N3O3.2HCl | 480.43 | CC(C1=CC=CC=C1C(N2CCN3CCN(C4=CC=CC=C4OC)CC3)=O)(C2=O)C.Cl.Cl |
| EOS-AX7646 | ZD 7114 hydrochloride | 129689-28-7 | C22H30N2O6.HCl | 454.95 | O[C@H](COC1=CC=CC=C1)CNCCOC(C=C2)=CC=C2OCC(NCCOC)=O.Cl |
| EOS-AX7647 | Immepip dihydrobromide | 164391-47-3 | C9H15N3.2HBr | 327.06 | C1(CC2=CN=CN2)CCNCC1.Br.Br |
| EOS-AX7648 | MM 77 dihydrochloride | 159187-70-9 | C19H27N3O3.2HCl | 418.36 | COC1=CC=CC=C1N2CCN(CC2)CCCCN3C(CCC3=O)=O.Cl.Cl |
| EOS-AX7649 | Olvanil | 58493-49-5 | C26H43NO3 | 417.63 | O=C(CCCCCCC/C=C\CCCCCCCC)NCC(C=C1OC)=CC=C1O |
| EOS-AX7650 | MK 212 hydrochloride | 61655-58-1 | C8H11ClN4.HCl | 235.12 | ClC1=CN=CC(N2CCNCC2)=N1.Cl |
| EOS-AX7651 | NS 398 | 123653-11-2 | C13H18N2O5S | 314.36 | O=S(NC(C(OC1CCCCC1)=C2)=CC=C2[N+]([O-])=O)(C)=O |
| EOS-AX7652 | WB 4101 hydrochloride | 2170-58-3 | C19H23NO5.HCl | 381.86 | COC1=CC=CC(OC)=C1OCCNC[C@H]2OC3=CC=CC=C3OC2.Cl |
| EOS-AX7653 | Zaprinast | 37762-06-4 | C13H13N5O2 | 271.28 | O=C1N=C(C2=CC=CC=C2OCCC)N=C3NNN=C31 |
| EOS-AX7654 | BRL 37344, sodium salt | 127299-93-8 | C19H21NO4ClNa | 385.82 | ClC1=CC([C@@H](CN[C@H](C)CC(C=C2)=CC=C2OCC([O-])=O)O)=CC=C1.[Na+] |
| EOS-AX7655 | CP 55,940 | 83002-04-4 | C24H40O3 | 376.58 | |
| EOS-AX7656 | Xamoterol hemifumarate | 73210-73-8 | C16H25N3O5.0.5C4H4O4 | 397.43 | OC1=CC=C(OCC(O)CNCC/N=C(O)/N2CCOCC2)C=C1.OC3=CC=C(OCC(O)CNCC/N=C(O)/N4CCOCC4)C=C3.O=C(O)/C([H])=C([H])/C(O)=O |
| EOS-AX7657 | 2-Iminopiperidine hydrochloride | 16011-96-4 | C5H10N2.HCl | 134.61 | NC1=NCCCC1.Cl |
| EOS-AX7658 | BD 1047 dihydrobromide | 138356-21-5 | C13H20Cl2N2.2HBr | 437.04 | ClC1=CC(CCN(C)CCN(C)C)=CC=C1Cl.Br.Br |
| EOS-AX7659 | Spermine tetrahydrochloride | 306-67-2 | C10H26N4.4HCl | 348.19 | NCCCNCCCCNCCCN.Cl.Cl.Cl.Cl |
| EOS-AX7660 | Spermidine trihydrochloride | 334-50-9 | C7H19N3.3HCl | 254.63 | NCCCCNCCCN.Cl.Cl.Cl |
| EOS-AX7661 | SYM 2206 | 173952-44-8 | C20H22N4O3 | 366.42 | O=C(NCCC)N([C@@H](C)C1=C2)N=C(C(C=C3)=CC=C3N)C1=CC4=C2OCO4 |
| EOS-AX7662 | 9-AC | 723-62-6 | C15H10O2 | 222.24 | OC(C1=C(C=CC=C2)C2=CC3=CC=CC=C13)=O |
| EOS-AX7663 | Diazoxide | 364-98-7 | C8H7ClN2O2S | 230.67 | ClC1=CC=C2NC(C)=NS(=O)(C2=C1)=O |
| EOS-AX7664 | Tacrine hydrochloride | 1684-40-8 | C13H14N2.HCl | 234.73 | NC1=C2CCCCC2=NC3=CC=CC=C13.Cl |
| EOS-AX7665 | 1-Phenylbiguanide hydrochloride | 55-57-2 | C8H11N5.HCl | 213.67 | NC(/N=C(N)/N)=N\C1=CC=CC=C1.Cl |
| EOS-AX7666 | EGLU | 170984-72-2 | C7H13NO4 | 175.18 | OC([C@@](CCC(O)=O)(CC)N)=O |
| EOS-AX7667 | CPPG | 183364-82-1 | C11H14NO5P | 271.21 | OC([C@@](C1CC1)(C(C=C2)=CC=C2P(O)(O)=O)N)=O |
| EOS-AX7668 | MPDC | 159262-32-5 | C7H9NO4 | 171.15 | OC([C@@H]1[C@H]2[C@@H]1CN[C@@H]2C(O)=O)=O |
| EOS-AX7669 | RS 17053 hydrochloride | 169505-93-5 | C24H29N2O2Cl.HCl | 449.42 | CC(CC1=CNC2=C1C=C(Cl)C=C2)(NCCOC3=CC=CC=C3OCC4CC4)C.Cl |
| EOS-AX7670 | Imiloxan hydrochloride | 81167-22-8 | C14H16N2O2.HCl | 280.75 | CCN1C(C[C@H]2OC3=CC=CC=C3OC2)=NC=C1.Cl |
| EOS-AX7671 | RS 79948 hydrochloride | 186002-54-0 | C19H28N2O3S.HCl | 400.96 | O=S(N1[C@@H]2[C@H](CCC1)CN(CCC3=C4C=CC(OC)=C3)[C@H]4C2)(CC)=O.Cl |
| EOS-AX7672 | RS 56812 hydrochloride | 143339-12-2 | C18H21N3O2.HCl | 347.84 | CN1C=C(C(C(N[C@@]2([H])CN3CCC2CC3)=O)=O)C4=CC=CC=C41.Cl |
| EOS-AX7673 | RS 67506 hydrochloride | 168986-61-6 | C18H28ClN3O4S.HCl | 454.41 | ClC(C=C(C(OC)=C1)C(CCC2CCN(CCNS(=O)(C)=O)CC2)=O)=C1N.Cl |
| EOS-AX7674 | Isamoltane hemifumarate | 874882-92-5 | C16H22N2O2.½C4H4O4 | 332.4 | CC(NCC(O)COC1=CC=CC=C1N2C=CC=C2)C.CC(NCC(O)COC3=CC=CC=C3N4C=CC=C4)C.O=C(O)/C([H])=C([H])/C(O)=O |
| EOS-AX7675 | Cyanopindolol hemifumarate | 106469-57-2 | C16H21N3O2.½C4H4O4 | 345.4 | CC(C)(NCC(O)COC1=CC=CC2=C1C=C(N2)C#N)C.CC(C)(NCC(O)COC3=CC=CC4=C3C=C(N4)C#N)C.O=C(O)/C([H])=C([H])/C(O)=O |
| EOS-AX7676 | Pindolol | 13523-86-9 | C14H20N2O2 | 248.32 | O[C@@H](COC1=C2C(NC=C2)=CC=C1)CNC(C)C |
| EOS-AX7677 | Spiperone hydrochloride | 2022-29-9 | C23H26FN3O2.HCl | 431.94 | FC1=CC=C(C=C1)C(CCCN2CC[C@@]3(CC2)N(C4=CC=CC=C4)CNC3=O)=O.Cl |
| EOS-AX7678 | AH 11110 hydrochloride | 179388-65-9 | C21H26N2O2.HCl | 374.91 | O[C@H](COC1=CC=CC=C1C2=CC=CC=C2)CC(N3CCCCC3)=N.Cl |
| EOS-AX7679 | ZD 7288 | 133059-99-1 | C15H21ClN4 | 292.81 | CCN(C1=CC=CC=C1)C2=C/C(N(C)C(C)=N2)=N\C.Cl |
| EOS-AX7680 | Chlorisondamine diiodide | 96750-66-2 | C14H20Cl4I2N2 | 611.95 | ClC(C(Cl)=C1Cl)=C2C[N+](CC2=C1Cl)(C)CC[N+](C)(C)C.[I-].[I-] |
| EOS-AX7681 | L-741,626 | 81226-60-0 | C20H21ClN2O | 340.85 | ClC1=CC=C(C=C1)C2(CCN(CC3=CNC4=CC=CC=C34)CC2)O |
| EOS-AX7682 | N-Desmethylclozapine | 6104-71-8 | C17H17ClN4 | 312.8 | ClC1=CC2=C(C=C1)N=C3C(C=CC=C3)=C(N2)N4CCNCC4 |
| EOS-AX7683 | E4CPG | 170846-89-6 | C11H13NO4 | 223.23 | OC([C@](CC)(C1=CC=C(C(O)=O)C=C1)N)=O |
| EOS-AX7684 | QX 314 bromide | 24003-58-5 | C16H27N2OBr | 343.31 | O=C(C[N+](CC)(CC)CC)NC1=C(C)C=CC=C1C.[Br-] |
| EOS-AX7685 | RS 16566 dihydrochloride | 1217788-97-0 | C18H23ClN4O.2HCl | 419.78 | CC(N1C=NC2=C(/C(O)=N/[C@@]3([H])CN4CCC3CC4)C=C(Cl)C=C21)C |
| EOS-AX7686 | LY 225910 | 133040-77-4 | C27H24BrN3O2 | 502.41 | BrC1=CC=C2NC=C(C2=C1)CCC(N3C4=CC=CC(OC(C)C)=C4)=NC5=CC=CC=C5C3=O |
| EOS-AX7687 | LY 235959 | 137433-06-8 | C11H20NO5P | 277.26 | OP(O)(C[C@@H]1C[C@H](C[C@@H](C(O)=O)NC2)[C@H]2CC1)=O |
| EOS-AX7688 | CGP 20712 dihydrochloride | 1216905-73-5 | C23H25F3N4O5.2HCl | 567.39 | CN(C(C1=CC=C(OCC(O)CNCCOC2=CC(C(O)=N)=C(O)C=C2)C=C1)=N3)C=C3C(F)(F)F.Cl.Cl |
| EOS-AX7689 | Nisoxetine hydrochloride | 57754-86-6 | C17H21NO2.HCl | 307.82 | CNCC[C@H](C1=CC=CC=C1)OC2=CC=CC=C2OC.Cl |
| EOS-AX7690 | PHCCC | 179068-02-1 | C17H14N2O3 | 294.31 | O=C([C@]1([C@H]/2C1)OC3=CC=CC=C3C2=N/O)NC4=CC=CC=C4 |
| EOS-AX7691 | CPCCOEt | 179067-99-3 | C13H13NO4 | 247.25 | O=C([C@]1([C@H]/2C1)OC3=CC=CC=C3C2=N/O)OCC |
| EOS-AX7692 | Methyllycaconitine citrate | 112825-05-5 | C37H50N2O10.C6H8O7 | 874.93 | |
| EOS-AX7693 | Piribedil dihydrochloride | 1451048-94-4 | C16H18N4O2.2HCl | 371.27 | C1(CN2CCN(C3=NC=CC=N3)CC2)=CC4=C(OCO4)C=C1 |
| EOS-AX7694 | CP 93129 dihydrochloride | 879089-64-2 | C12H13N3O.2HCl | 288.18 | OC1=NC(C(C2=CCNCC2)=CN3)=C3C=C1.Cl.Cl |
| EOS-AX7695 | 4-P-PDOT | 134865-74-0 | C19H21NO | 279.38 | O=C(CC)N[C@@H]1C[C@H](C2=CC=CC=C2)C3=CC=CC=C3C1 |
| EOS-AX7696 | 8-M-PDOT | 134865-70-6 | C14H19NO2 | 233.31 | O=C(CC)N[C@@H]1CCC2=C(C(OC)=CC=C2)C1 |
| EOS-AX7697 | ZM 241385 | 139180-30-6 | C16H15N7O2 | 337.34 | OC1=CC=C(C=C1)CCNC2=NC3=NC(C4=CC=CO4)=NN3C(N)=N2 |
| EOS-AX7698 | TPMPA | 182485-36-5 | C6H12NO2P | 161.14 | O[P@@](C1=CCNCC1)(C)=O |
| EOS-AX7699 | 1-EBIO | 10045-45-1 | C9H10N2O | 162.19 | O=C1N(CC)C2=CC=CC=C2N1 |
| EOS-AX7700 | N-Methyllidocaine iodide | 1462-71-1 | C15H25IN2O | 376.28 | O=C(C[N+](CC)(C)CC)NC1=C(C)C=CC=C1C.[I-] |
| EOS-AX7701 | QX 222 | 5369-00-6 | C13H21ClN2O | 256.77 | CC1=C(/N=C([O-])/C[N+](C)(C)C)C(C)=CC=C1 |
| EOS-AX7702 | NBQX disodium salt | 479347-86-9 | C12H6N4O6SNa2 | 380.24 | O=S(N)(C1=CC=CC2=C1C([N+]([O-])=O)=CC(N=C3[O-])=C2N=C3[O-])=O.[Na+].[Na+] |
| EOS-AX7703 | CNQX disodium salt | 479347-85-8 | C9H2N4O4Na2 | 276.12 | [O-]C(N=C(C=C1[N+]([O-])=O)C(C=C1C#N)=N2)=C2[O-].[Na+].[Na+] |
| EOS-AX7704 | 1-BCP | 34023-62-6 | C13H15NO3 | 233.27 | O=C(C1=CC=C2OCOC2=C1)N3CCCCC3 |
| EOS-AX7705 | CHPG | 170846-74-9 | C8H8NO3Cl | 201.61 | ClC(C=C1)=C(C=C1O)[C@@H](C(O)=O)N |
| EOS-AX7706 | Zinterol hydrochloride | 37000-20-7 | C19H26N2O4S | 414.95 | O[C@@H](C(C=C1NS(=O)(C)=O)=CC=C1O)CNC(C)(C)CC2=CC=CC=C2.Cl |
| EOS-AX7707 | A 61603 hydrobromide | 107756-30-9 | C14H19N3O3S.HBr | 390.29 | OC1=C(C2=C(C=C1)[C@@H](C3=NCCN3)CCC2)NS(=O)(C)=O.Br |
| EOS-AX7708 | GR 55562 dihydrochloride | 159533-25-2 | C23H25N3O2.2HCl | 448.39 | CN(CCCC1=CC(/C(O)=N/C2=CC=C(C3=CC=NC=C3)C=C2)=CC=C1O)C |
| EOS-AX7709 | WIN 64338 hydrochloride | 163727-74-0 | C45H68ClN4OP.HCl | 783.95 | CCCC[P+](CCCC)(CC1=CC=C(NC([C@]([N-]/C(NC2CCCCC2)=N\C3CCCCC3)([H])CC4=CC5=CC=CC=C5C=C4)=O)C=C1)CCCC.Cl.Cl |
| EOS-AX7710 | BW 723C86 hydrochloride | 160521-72-2 | C16H18N2OS.HCl | 322.85 | N[C@H](C)CC(C1=C2)=CNC1=CC=C2OCC3=CC=CS3.Cl |
| EOS-AX7711 | (S)-(-)-Pindolol | 26328-11-0 | C14H20N2O2 | 248.32 | O[C@H](COC1=C2C(NC=C2)=CC=C1)CNC(C)C |
| EOS-AX7712 | (-)-Quinpirole hydrochloride | 85798-08-9 | C13H21N3.HCl | 255.79 | CCCN1C2[C@@H](CC(NN=C3)=C3C2)CCC1.Cl |
| EOS-AX7713 | 2-Methylthioadenosine triphosphate tetrasodium salt | 100020-57-3 | C11H14N5Na4O13P3S | 641.2 | CSC1=NC(N)=C(N=CN2[C@@]3([H])[C@@](O)([H])[C@@](O)([H])[C@@](O3)([H])COP([O-])(OP([O-])(OP([O-])([O-])=O)=O)=O)C2=N1.[Na+].[Na+].[Na+].[Na+] |
| EOS-AX7714 | PD 168077 maleate | 630117-19-0 | C20H22N4O.C4H4O4 | 450.49 | CC1=CC(/C(O)=N/CN2CCN(C3=CC=CC=C3C#N)CC2)=CC=C1.O=C(O)/C([H])=C([H])\C(O)=O |
| EOS-AX7715 | Oxotremorine M | 3854-04-4 | C11H19IN2O | 322.19 | O=C1N(C#CCC[N+](C)(C)C)CCC1.[I-] |
| EOS-AX7716 | Senktide | 106128-89-6 | C40H55N7O11S | 841.97 | O=C([C@H](CC1=CC=CC=C1)NC([C@H](CC(O)=O)NC(CCC(O)=O)=O)=O)N(C)[C@H](C(NCC(N[C@H](C(N[C@H](C(N)=O)CCSC)=O)CC(C)C)=O)=O)CC2=CC=CC=C2 |
| EOS-AX7717 | Zolantidine dimaleate | 104076-39-3 | C22H27N3OS.2C4H4O4 | 613.68 | OC(/C=C/C(O)=O)=O.OC(/C=C/C(O)=O)=O.N1(CC2=CC=CC(OCCCNC3=NC4=CC=CC=C4S3)=C2)CCCCC1 |
| EOS-AX7718 | Pirenzepine dihydrochloride | 29868-97-1 | C19H21N5O2.2HCl | 424.33 | O=C(CN1CCN(C)CC1)N2C3=CC=CC=C3C(NC4=CC=CN=C24)=O.Cl.Cl |
| EOS-AX7719 | AGN 192403 hydrochloride | 1021868-90-5 | C10H19N.HCl | 189.73 | CC([C@]1([H])[C@@]2([H])CC[C@]([C@@]1([H])N)([H])C2)C.Cl |
| EOS-AX7720 | (RS)-APICA | 170847-18-4 | C10H12NO5P | 257.18 | OC([C@@]1(CCC2=CC(P(O)(O)=O)=CC=C12)N)=O |
| EOS-AX7721 | (RS)-AMPA hydrobromide | 171259-81-7 | C7H10N2O4.HBr | 267.08 | O=C1NOC(C)=C1C[C@H](C(O)=O)N.Br |
| EOS-AX7722 | (-)-Lobeline hydrochloride | 134-63-4 | C22H27NO2.HCl | 373.92 | O[C@H](C1=CC=CC=C1)C[C@H]2N(C)[C@H](CC(C3=CC=CC=C3)=O)CCC2.Cl |
| EOS-AX7723 | (+)-SK&F 10047 hydrochloride | 133005-41-1 | C17H23NO.HCl | 293.84 | OC1=CC2=C(C=C1)CC3N(CC=C)CCC2(C)C3C.Cl |
| EOS-AX7724 | (R)-(+)-8-Hydroxy-DPAT hydrobromide | 78095-19-9 | C16H25NO.HBr | 328.29 | OC1=CC=CC2=C1C[C@@H](CC2)N(CCC)CCC.Br |
| EOS-AX7725 | SKF 89976A hydrochloride | 85375-15-1 | C22H25NO2.HCl | 371.91 | OC([C@H]1CN(CC/C=C(C2=CC=CC=C2)/C3=CC=CC=C3)CCC1)=O.Cl |
| EOS-AX7726 | CFM-2 | 178616-26-7 | C17H17N3O3 | 311.34 | O=C1NN=C(C(C=C2)=CC=C2N)C(C(C1)=C3)=CC(OC)=C3OC |
| EOS-AX7727 | Iberiotoxin | 129203-60-7 | C179H274N50O55S7 | 4230 | |
| EOS-AX7728 | Charybdotoxin | 95751-30-7 | C176H277N57O55S7 | 4295.95 | |
| EOS-AX7729 | CGP 54626 hydrochloride | 149184-21-4 | C18H28Cl2NO3P.HCl | 444.76 | ClC1=CC([C@H](C)NC[C@@H](C[P@@](O)(CC2CCCCC2)=O)O)=CC=C1Cl.Cl |
| EOS-AX7730 | 8-Bromo-cGMP, sodium salt | 51116-01-9 | C10H10BrN5NaO7P | 446.09 | BrC1=NC2=C(NC(N)=NC2=O)N1[C@@H]3O[C@@H]4[C@H]([C@H]3O)O[P@](OC4)([O-])=O.[Na+] |
| EOS-AX7731 | BU 226 hydrochloride | 1186195-56-1 | C12H11N3.HCl | 233.7 | C12=CC=CC=C1C=NC(C3=NCCN3)=C2.Cl |
| EOS-AX7732 | Procaterol hydrochloride | 62929-91-3 | C16H22N2O3.HCl | 326.82 | O[C@H](C(C(C=C1)=C2NC1=O)=CC=C2O)[C@H](CC)NC(C)C.Cl |
| EOS-AX7733 | 2-Cl-IB-MECA | 163042-96-4 | C18H18ClIN6O4 | 544.74 | IC1=CC(CNC(N=C(N=C23)Cl)=C3N=CN2[C@@H]([C@@H]4O)O[C@H](C(NC)=O)[C@H]4O)=CC=C1 |
| EOS-AX7734 | AF-DX 116 | 102394-31-0 | C24H31N5O2 | 421.54 | O=C(CN1[C@H](CN(CC)CC)CCCC1)N2C3=CC=CC=C3C(NC4=CC=CN=C24)=O |
| EOS-AX7735 | ATPA | 140158-50-5 | C10H16N2O4 | 228.25 | O=C1NOC(C(C)(C)C)=C1C[C@H](C(O)=O)N |
| EOS-AX7736 | GR 103691 | 162408-66-4 | C30H35N3O3 | 485.63 | O=C(C1=CC=C(C2=CC=C(C(C)=O)C=C2)C=C1)NCCCCN3CCN(C4=CC=CC=C4OC)CC3 |
| EOS-AX7737 | ACPT-II | 195209-04-2 | C8H11NO6 | 217.18 | OC([C@]1(C[C@@H](C(O)=O)[C@@H](C(O)=O)C1)N)=O |
| EOS-AX7738 | CGP 37157 | 75450-34-9 | C15H11Cl2NOS | 324.22 | ClC1=CC=CC=C1[C@@H](C2=C3)SCC(NC2=CC=C3Cl)=O |
| EOS-AX7739 | AM 281 | 202463-68-1 | C21H19Cl2IN4O2 | 557.22 | IC1=CC=C(C=C1)C2=C(C)C(C(NN3CCOCC3)=O)=NN2C(C(Cl)=C4)=CC=C4Cl |
| EOS-AX7740 | AM 404 | 198022-70-7 | C26H37NO2 | 395.58 | O=C(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)NC(C=C1)=CC=C1O |
| EOS-AX7741 | (R)-(+)-Methanandamide | 157182-49-5 | C23H39NO2 | 361.57 | |
| EOS-AX7742 | Telenzepine dihydrochloride | 147416-96-4 | C19H22N4O2S.2HCl | 443.39 | O=C(CN1CCN(C)CC1)N2C3=C(C)SC=C3C(NC4=CC=CC=C24)=O.Cl.Cl |
| EOS-AX7743 | (S)-(+)-Niguldipine hydrochloride | 113145-69-0 | C36H39N3O6.HCl | 646.18 | O=C(C1=C(C)NC(C)=C(C(OC)=O)[C@@H]1C2=CC=CC([N+]([O-])=O)=C2)OCCCN3CCC(C4=CC=CC=C4)(C5=CC=CC=C5)CC3.Cl |
| EOS-AX7744 | (R)-(-)-Niguldipine hydrochloride | C21H23N5O | 361.45 | O=C(C1=C(C)NC(C)=C(C(OC)=O)[C@H]1C2=CC=CC([N+]([O-])=O)=C2)OCCCN3CCC(C4=CC=CC=C4)(C5=CC=CC=C5)CC3 | |
| EOS-AX7745 | Harmane | 486-84-0 | C12H10N2 | 182.22 | CC1=C2NC3=CC=CC=C3C2=CC=N1 |
| EOS-AX7746 | BRL 44408 maleate | 118343-19-4 | C13H17N3.C4H4O4 | 331.37 | CC1C2=CC=CC=C2CN1CC3=NCCN3.O=C(O)/C([H])=C([H])\C(O)=O |
| EOS-AX7747 | CGP 12177 hydrochloride | 64208-32-8 | C14H21N3O3.HCl | 315.8 | O[C@@H](COC1=CC=CC(N2)=C1NC2=O)CNC(C)(C)C.Cl |
| EOS-AX7748 | Spermine NONOate | 136587-13-8 | C10H26N6O2 | 262.35 | ON(N=O)N(CCCN)CCCCNCCCN |
| EOS-AX7749 | Resiniferatoxin | 57444-62-9 | C37H40O9 | 628.72 | O[C@@]12[C@@H](C=C(C)C2=O)[C@]34O[C@@](O[C@@]5(C(C)=C)C[C@H]4C)(CC6=CC=CC=C6)O[C@@H]5[C@@H]3C=C(COC(CC(C=C7OC)=CC=C7O)=O)C1 |
| EOS-AX7750 | Thapsigargin | 67526-95-8 | C34H50O12 | 650.76 | O[C@@]([C@H]1OC(CCC)=O)([C@]2(C)O)[C@H](C([C@H]([C@@H]3OC(CCCCCCC)=O)[C@@](C1)(C)OC(C)=O)=C(C)[C@@H]3OC(/C(C)=C\C)=O)OC2=O |
| EOS-AX7751 | SKF 96365 hydrochloride | 130495-35-1 | C22H26N2O3.HCl | 402.92 | COC1=CC=C(C=C1)[C@@H](CN2C=CN=C2)OCCCC(C=C3)=CC=C3OC.Cl |
| EOS-AX7752 | Siguazodan | 115344-47-3 | C14H16N6O | 284.32 | O=C1NN=C(C(C=C2)=CC=C2N/C(NC#N)=N/C)[C@H](C)C1 |
| EOS-AX7753 | Neurokinin A (porcine) | 86933-74-6 | C50H80N14O14S | 1133.3 | |
| EOS-AX7754 | RR-src | 81156-93-6 | C64H106N22O21 | 1519.7 | |
| EOS-AX7755 | Substance P | 33507-63-0 | C63H98N18O13S | 1347.6 | |
| EOS-AX7756 | DAMGO | 78123-71-4 | C26H35N5O6 | 513.7 | O=C([C@H](CC1=CC=CC=C1)N(C)C(CNC([C@@H](C)NC([C@H](CC(C=C2)=CC=C2O)N)=O)=O)=O)NCCO |
| EOS-AX7757 | Neuropeptide Y 13-36 (porcine) | 113662-54-7 | C135H209N41O36 | 2983 | |
| EOS-AX7758 | [Sar9,Met(O2)11]-Substance P | 110880-55-2 | C64H100N18O15S | 1393 | |
| EOS-AX7759 | Galanin (1-30) (human) | 119418-04-1 | C139H210N42O43 | 3157.41 | |
| EOS-AX7760 | PACAP 1-38 | 137061-48-4 | C203H331N63O53S | 4535 | |
| EOS-AX7761 | BQ-123 | 136553-81-6 | C31H42N6O7 | 611 | O=C([C@H]1N(C([C@H](CC(O)=O)NC([C@H](CC2=CNC3=CC=CC=C23)NC4=O)=O)=O)CCC1)N[C@@H](C(N[C@H]4CC(C)C)=O)C(C)C |
| EOS-AX7762 | Mastoparan | 72093-21-1 | C70H131N19O15 | 1479 | |
| EOS-AX7763 | Melittin | 20449-79-0 | C131H229N39O31 | 2847 | |
| EOS-AX7764 | NF 279 | 202983-32-2 | C49H30N6Na6O23S6 | 1401.1 | [O-]/C(C1=CC=C(NC(NC2=CC=C(/C([O-])=N/C3=CC=C(C(NC4=C5C(C=C(S([O-])(=O)=O)C=C5S(O)(=O)=O)=C(S([O-])(=O)=O)C=C4)=O)C=C3)C=C2)=O)C=C1)=N\C6=CC=C(C(NC7=C8C(C=C(S([O-])(=O)=O)C=C8S(O)(=O)=O)=C(S([O-])(=O)=O)C=C7)=O)C=C6.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] |
| EOS-AX7765 | Nω-Propyl-L-arginine hydrochloride | 137361-05-8 | C9H20N4O2.HCl | 252.74 | OC([C@H](CCCN/C(N)=N/CCC)N)=O.Cl |
| EOS-AX7766 | MRS 2219 | 14141-47-0 | C8H10NO5P | 231.14 | OC1=C(CO[P@@](OC2)(O)=O)C2=CN=C1C |
| EOS-AX7767 | SR 57227 hydrochloride | 77145-61-0 | C10H14ClN3.HCl | 248.15 | ClC1=CC=CC(N2CCC(CC2)N)=N1.Cl |
| EOS-AX7768 | SC 19220 | 19395-87-0 | C16H14ClN3O3 | 331.76 | ClC1=CC=C2OC3=CC=CC=C3CN(C(NNC(C)=O)=O)C2=C1 |
| EOS-AX7769 | (2R,4R)-APDC | 169209-63-6 | C6H10N2O4 | 174.16 | OC([C@]1(C[C@H](C(O)=O)NC1)N)=O |
| EOS-AX7770 | SIB 1893 | 6266-99-5 | C14H13N | 195.26 | CC1=CC=CC(/C=C\C2=CC=CC=C2)=N1 |
| EOS-AX7771 | SIB 1757 | 31993-01-8 | C12H11N3O | 213.24 | O=C1/C(N=C(C)C=C1)=N/NC2=CC=CC=C2 |
| EOS-AX7772 | MRS 1220 | 183721-15-5 | C21H14ClN5O2 | 403.83 | ClC1=CC=C2N=C(NC(CC3=CC=CC=C3)=O)N4N=C(C5=CC=CO5)N=C4C2=C1 |
| EOS-AX7773 | DH 97 | 220339-00-4 | C22H26N2O | 334.46 | CCCC/C(O)=N/CCC(C1=CC=CC=C1N2)=C2CC3=CC=CC=C3 |
| EOS-AX7774 | IDRA 21 | 22503-72-6 | C8H9ClN2O2S | 232.68 | ClC1=CC=C2N[C@H](C)NS(=O)(C2=C1)=O |
| EOS-AX7775 | (RS)-PPG | 120667-15-4 | C8H10NO5P | 231.14 | OP(O)(C(C=C1)=CC=C1NCC(O)=O)=O |
| EOS-AX7776 | SB 224289 hydrochloride | 180084-26-8 | C32H32N4O3.HCl | 557.09 | O=C(C1=CC=C(C2=CC=C(C3=NOC(C)=N3)C=C2C)C=C1)N4C5=C(CC4)C=C6OC[C@]7(C6=C5)CCN(C)CC7.Cl |
| EOS-AX7777 | DMPQ dihydrochloride | 1123491-15-5 | C16H14N2O2.2HCl | 339.22 | COC1=C2C(N=CC(C3=CC=NC=C3)=C2)=CC(OC)=C1.Cl.Cl |
| EOS-AX7778 | 2-APB | 524-95-8 | C14H16BNO | 225.1 | NCCOB(C1=CC=CC=C1)C2=CC=CC=C2 |
| EOS-AX7779 | TCPOBOP | 76150-91-9 | C16H8Cl4N2O2 | 402.06 | ClC1=CC(Cl)=CN=C1OC(C=C2)=CC=C2OC(C(Cl)=C3)=NC=C3Cl |
| EOS-AX7780 | Cytochalasin D | 22144-77-0 | C30H37NO6 | 507.63 | O[C@@H]1[C@@H](/C=C/C[C@@H](C)C2=O)[C@]3([C@@H](C=C[C@]2(C)O)OC(C)=O)[C@@H]([C@@H](C)C1=C)[C@H](CC4=CC=CC=C4)NC3=O |
| EOS-AX7781 | A23187, free acid | 52665-69-7 | C29H37N3O6 | 523.63 | O=C(C1=CC=CN1)[C@@H](C)[C@@H]2O[C@@]3([C@@H](C)C[C@@H]2C)O[C@@H](CC4=NC5=C(C(O)=O)C(NC)=CC=C5O4)[C@@H](C)CC3 |
| EOS-AX7782 | Cyclopiazonic acid | 18172-33-3 | C20H20N2O3 | 336.39 | OC1=C(C(C)=O)C(N2C(C)(C)[C@@H](CC3=C4C5=CNC4=CC=C3)[C@H]5[C@@H]21)=O |
| EOS-AX7783 | BHQ | 88-58-4 | C14H22O2 | 222.33 | OC(C(C(C)(C)C)=C1)=CC(C(C)(C)C)=C1O |
| EOS-AX7784 | LY 367385 | 198419-91-9 | C10H11NO4 | 209.2 | OC([C@H](C1=CC=C(C(O)=O)C=C1C)N)=O |
| EOS-AX7785 | CCMQ | 132623-44-0 | C12H9NO4 | 231.21 | OC(CC1=CC2=CC=CC=C2N=C1C(O)=O)=O |
| EOS-AX7786 | NF 023 | 104869-31-0 | C35H20N4Na6O21S6 | 1162.86 | OS(=O)(C1=C2C(C(S(O)(=O)=O)=CC=C2NC(C3=CC=CC(NC(NC4=CC(C(NC(C(C5=CC(S(O)(=O)=O)=C6)=C6S(O)(=O)=O)=CC=C5S(O)(=O)=O)=O)=CC=C4)=O)=C3)=O)=CC(S(O)(=O)=O)=C1)=O.[NaH].[NaH].[NaH].[NaH].[NaH].[NaH] |
| EOS-AX7787 | CGS 19755 | 110347-85-8 | C7H14NO5P | 223.17 | OP(O)(C[C@H]1C[C@@H](C(O)=O)NCC1)=O |
| EOS-AX7788 | SB 216641 hydrochloride | 193611-67-5 | C28H30N4O4.HCl | 523.03 | CC1=CC(C2=NOC(C)=N2)=CC=C1C3=CC=C(C(NC4=CC(OCCN(C)C)=C(OC)C=C4)=O)C=C3.Cl |
| EOS-AX7789 | CGP 35348 | 123690-79-9 | C8H20NO4P | 225.22 | O[P@@](CCCN)(C(OCC)OCC)=O |
| EOS-AX7790 | CGP 52432 | 139667-74-6 | C15H24Cl2NO4P | 384.24 | ClC1=CC(CNCCC[P@](O)(C(OCC)OCC)=O)=CC=C1Cl |
| EOS-AX7791 | CGP 46381 | 123691-14-5 | C10H22NO2P | 219.26 | O[P@@](CC1CCCCC1)(CCCN)=O |
| EOS-AX7792 | CY 208-243 | 100999-26-6 | C19H18N2 | 274.36 | CN1[C@@H](C2)[C@H](C3=CC=CC=C3C1)C4=C5C2=CNC5=CC=C4 |
| EOS-AX7793 | SDZ 220-040 | 174575-40-7 | C16H16Cl2NO6P | 420.19 | ClC1=CC(Cl)=C(C2=CC(C[C@@](N)([H])C(O)=O)=C(O)C(CP(O)(O)=O)=C2)C=C1 |
| EOS-AX7794 | (S)-WAY 100135 dihydrochloride | 149007-54-5 | C24H33N3O2.2HCl | 468.47 | CC(C)(/N=C(O)/[C@](C1=CC=CC=C1)([H])CN2CCN(C3=CC=CC=C3OC)CC2)C.Cl.Cl |
| EOS-AX7795 | SDZ SER 082 fumarate | 141474-54-6 | C15H20N2.C4H4O4 | 344.41 | CN(C[C@]12[H])CC[C@]1([H])CN3CCC4=C3C2=CC=C4.O=C(O)/C([H])=C([H])/C(O)=O |
| EOS-AX7796 | 1-Deoxymannojirimycin hydrochloride | 73465-43-7 | C6H13NO4.HCl | 199.63 | O[C@@H]([C@@H]1O)[C@@H](CO)NC[C@H]1O.Cl |
| EOS-AX7797 | EHNA hydrochloride | 81408-49-3 | C14H23N5O.HCl | 313.83 | O[C@H](C)[C@H](CCCCCC)N1C2=NC=NC(N)=C2N=C1.Cl |
| EOS-AX7798 | SR 95531 hydrobromide | 104104-50-9 | C15H17N3O3.HBr | 368.23 | COC1=CC=C(C(C=CC2=N)=NN2CCCC(O)=O)C=C1.Br |
| EOS-AX7799 | GR 144053 trihydrochloride | 1215333-48-4 | C18H27N5O2.3HCl | 454.83 | NC(C1=CC=C(N2CCN(C3CCN(CC(O)=O)CC3)CC2)C=C1)=N.Cl.Cl.Cl |
| EOS-AX7800 | D-CPP-ene | 117414-74-1 | C8H15N2O5P | 250.19 | OC([C@@H]1NCCN(C/C=C/P(O)(O)=O)C1)=O |
| EOS-AX7801 | RJR 2429 dihydrochloride | 1021418-53-0 | C12H16N2.2HCl | 261.19 | C1(CC2C3=CN=CC=C3)CCN2CC1.Cl.Cl |
| EOS-AX7802 | GR 159897 | 158848-32-9 | C23H27FN2O2S | 414.54 | FC1=CC=C2NC=C(C2=C1)CCN3CCC(CC3)(CS(C4=CC=CC=C4)=O)OC |
| EOS-AX7803 | (-)-Xestospongin C | 88903-69-9 | C28H50N2O2 | 446.71 | N12[C@@H]([C@@H](CCCCCC[C@@H]3O[C@@H]4N(CC3)CCC[C@@H]4CCCCCC5)CCC2)O[C@@H]5CC1 |
| EOS-AX7804 | GNTI dihydrochloride | 351183-88-5 | C27H29N5O3.2HCl | 544.48 | N=C(NC1=CC(C(C[C@@]2(O)[C@@]3([H])CC4=C5C(O6)=C(O)C=C4)=C7[C@@]6([H])[C@@]25CCN3CC8CC8)=C(N7)C=C1)N.Cl.Cl |
| EOS-AX7805 | ARL 67156 trisodium salt | 1021868-83-6 | C15H21Br2N5O12P3.3Na | 785.06 | CCN(C1=C(N=CN2[C@@]3([H])[C@@](O)([H])[C@@](O)([H])[C@@](O3)([H])COP(O)(OP(C(Br)(P([O-])([O-])=O)Br)([O-])=O)=O)C2=NC=N1)CC.[Na+].[Na+].[Na+] |
| EOS-AX7806 | LY 231617 | 141545-89-3 | C17H29NO.HCl | 299.88 | OC(C(C(C)(C)C)=CC(CNCC)=C1)=C1C(C)(C)C.Cl |
| EOS-AX7807 | KT 5823 | 126643-37-6 | C29H25N3O5 | 495.53 | O=C([C@@]([C@]1(C)O[C@@H]2N3C4=C5N1C6=CC=CC=C6C5=C(CN(C)C7=O)C7=C4C8=CC=CC=C38)(C2)OC)OC |
| EOS-AX7808 | Anisomycin | 22862-76-6 | C14H19NO4 | 265.31 | O[C@@H]1[C@H]([C@@H](CC(C=C2)=CC=C2OC)NC1)OC(C)=O |
| EOS-AX7809 | Ochratoxin A | 303-47-9 | C20H18ClNO6 | 403.82 | ClC1=C(C2=C(C(C(N[C@H](C(O)=O)CC3=CC=CC=C3)=O)=C1)O)C[C@H](C)OC2=O |
| EOS-AX7810 | Loreclezole hydrochloride | 117857-45-1 | C10H6Cl3N3.HCl | 311 | Cl/C(C(C(Cl)=C1)=CC=C1Cl)=C/N2N=CN=C2.Cl |
| EOS-AX7811 | CI 966 hydrochloride | 110283-66-4 | C23H21F6NO3.HCl | 509.87 | FC(F)(C1=CC=C(C=C1)C(C2=CC=C(C(F)(F)F)C=C2)OCCN3CCC=C(C(O)=O)C3)F.Cl |
| EOS-AX7812 | Abn-CBD | 22972-55-0 | C21H30O2 | 314.47 | OC1=C(C(CCCCC)=CC(O)=C1)[C@@H]2[C@H](C(C)=C)CCC(C)=C2 |
| EOS-AX7813 | (S)-3,4-DCPG | 201730-11-2 | C10H9NO6 | 239.18 | OC([C@H](C1=CC=C(C(O)=O)C(C(O)=O)=C1)N)=O |
| EOS-AX7814 | BW-B 70C | 134470-38-5 | C17H17FN2O3 | 316.33 | FC1=CC=C(C=C1)OC2=CC(/C=C/[C@@H](C)N(C(N)=O)O)=CC=C2 |
| EOS-AX7815 | Ciglitazone | 74772-77-3 | C18H23NO3S | 333.44 | O=C1NC(S[C@@H]1CC2=CC=C(C=C2)OCC3(C)CCCCC3)=O |
| EOS-AX7816 | PPNDS | 1021868-77-8 | C18H11N4Na4O14PS2 | 694.36 | [O-]S(=O)(C1=CC(N/N=C(C(COP([O-])([O-])=O)=C2C=O)\N=C(C)C2=O)=CC(C1=CC([N+]([O-])=O)=C3)=C3S([O-])(=O)=O)=O.[Na+].[Na+].[Na+].[Na+] |
| EOS-AX7817 | UCL 1684 | 199934-16-2 | C34 H30 N4 . 2 C2 F3 O2 | 720.66 | FC(F)(F)C(O)=O.FC(F)(F)C(O)=O.C1(CN=C(C2=CC=CC=C23)C=CN3CC4=CC5=CC=C4)=CC=C(CN=C(C6=CC=CC=C67)C=CN7C5)C=C1 |
| EOS-AX7818 | MK 886 | 118414-82-7 | C27H34ClNO2S | 472.08 | ClC1=CC=C(C=C1)CN(C2=CC=C(C(C)C)C=C32)C(CC(C)(C(O)=O)C)=C3SC(C)(C)C |
| EOS-AX7819 | CP 94253 hydrochloride | 845861-39-4 | C15H19N3O.HCl | 293.8 | CCCOC1=NC(C(C2=CCNCC2)=CN3)=C3C=C1.Cl |
| EOS-AX7820 | ACPA | 229021-64-1 | C23H37NO | 343.55 | |
| EOS-AX7821 | ACEA | 220556-69-4 | C22H36ClNO | 365.99 | |
| EOS-AX7822 | GR 113808 | 144625-51-4 | C19H27N3O4S | 393.5 | O=C(C1=CN(C)C2=CC=CC=C12)OCC3CCN(CCNS(=O)(C)=O)CC3 |
| EOS-AX7823 | Butabindide oxalate | 185213-03-0 | C17H25N3O2.C2H2O4 | 393.44 | O=C([C@H]1N(C([C@H](CC)N)=O)C2=CC=CC=C2C1)NCCCC.OC(C(O)=O)=O |
| EOS-AX7824 | RX 821002 hydrochloride | 109544-45-8 | C12H14N2O3.HCl | 270.72 | CO[C@@]1(C2=NCCN2)OC3=CC=CC=C3OC1.Cl |
| EOS-AX7825 | BADGE | 1675-54-3 | C21H24O4 | 340.42 | CC(C(C=C1)=CC=C1OC[C@H]2OC2)(C)C(C=C3)=CC=C3OC[C@H]4OC4 |
| EOS-AX7826 | L-655,708 | 130477-52-0 | C18H19N3O4 | 341.37 | CCOC(C(N=CN12)=C2[C@]3([H])CCCN3C(C4=C1C=CC(OC)=C4)=O)=O |
| EOS-AX7827 | Lavendustin A | 125697-92-9 | C21H19NO6 | 381.38 | OC(C(CN(C(C=C1C(O)=O)=CC=C1O)CC2=CC=CC=C2O)=C3)=CC=C3O |
| EOS-AX7828 | Anandamide | 94421-68-8 | C22H37NO2 | 347.54 | |
| EOS-AX7829 | AF-DX 384 | 118290-26-9 | C27H38N6O2 | 478.64 | CCCN(CC1CCCCN1CC/N=C(O)/N2C3=CC=CC=C3C(O)=NC4=C2N=CC=C4)CCC |
| EOS-AX7830 | Nafadotride | 149649-22-9 | C22H27N3O2 | 365.47 | O=C(C1=CC(C#N)=C2C(C=CC=C2)=C1OC)NC[C@@H]3N(CCCC)CCC3 |
| EOS-AX7831 | Arvanil | 128007-31-8 | C28H41NO3 | 439.64 | O=C(CCC/C=C/C/C=C/C/C=C/C/C=C/CCCCC)NCC(C=C1OC)=CC=C1O |
| EOS-AX7832 | P1075 | 60559-98-0 | C12H17N5 | 231.3 | N#CN/C(NC1=CC=CN=C1)=N\C(C)(C)CC |
| EOS-AX7833 | MG 624 | 77257-42-2 | C22H30NOI | 451.39 | CC[N+](CC)(CC)CCOC1=CC=C(/C=C/C2=CC=CC=C2)C=C1.[I-] |
| EOS-AX7834 | U 99194 maleate | 234757-41-6 | C17H27NO2.C4H4O4 | 393.48 | CCCN(CCC)C(CC1=C2)CC1=CC(OC)=C2OC.OC(/C=C/C(O)=O)=O |
| EOS-AX7835 | VUF 5574 | 280570-45-8 | C21H17N5O2 | 371.39 | O=C(NC1=CC=CC=C1OC)NC2=NC(C3=CC=CN=C3)=NC4=CC=CC=C42 |
| EOS-AX7836 | 5'-Iodoresiniferatoxin | 535974-91-5 | C37H39IO9 | 754.6 | IC(C=C(C=C1OC)CC(OCC2=C[C@@H]3[C@]([C@H](C)C4)([C@H](C=C(C)C5=O)[C@@]5(C2)O)O[C@@]6(CC7=CC=CC=C7)O[C@H]3[C@@]4(C(C)=C)O6)=O)=C1O |
| EOS-AX7837 | PD 81723 | 132861-87-1 | C14H12F3NOS | 299.31 | FC(F)(C1=CC(C(C2=C(N)SC(C)=C2C)=O)=CC=C1)F |
| EOS-AX7838 | UBP1112 | 339526-74-8 | C10H14NO5P | 259.2 | OC([C@@](C1=CC=C(C(C)=C1)P(O)(O)=O)(C)N)=O |
| EOS-AX7839 | Sphingosine-1-phosphate | 26993-30-6 | C18H38NO5P | 379.48 | O[C@H](/C=C/CCCCCCCCCCCCC)[C@H](COP(O)(O)=O)N |
| EOS-AX7840 | SB 204741 | 152239-46-8 | C14H14N4OS | 286.35 | O=C(NC1=CC(C)=NS1)NC2=CC=C3N(C)C=CC3=C2 |
| EOS-AX7841 | SB 228357 | 181629-93-6 | C22H17F4N3O2 | 431.39 | FC(F)(C(C=C1N(C(NC2=CC(F)=CC(C3=CC=CN=C3)=C2)=O)CCC1=C4)=C4OC)F |
| EOS-AX7842 | SB 218795 | 174635-53-1 | C25H20N2O3 | 396.44 | O=C(C1=CC(C2=CC=CC=C2)=NC3=CC=CC=C13)N[C@H](C(OC)=O)C4=CC=CC=C4 |
| EOS-AX7843 | Cromakalim | 94470-67-4 | C16H18N2O3 | 286.33 | O[C@H](C(C)(C)OC1=C2C=C(C#N)C=C1)[C@@H]2N3CCCC3=O |
| EOS-AX7844 | Levcromakalim | 94535-50-9 | C16H18N2O3 | 286.33 | O[C@H](C(C)(C)OC1=C2C=C(C#N)C=C1)[C@@H]2N3CCCC3=O |
| EOS-AX7845 | SB 221284 | 196965-14-7 | C16H14F3N3OS | 353.36 | FC(F)(C(C=C1N(C(NC2=CC=CN=C2)=O)CCC1=C3)=C3SC)F |
| EOS-AX7846 | L-152,804 | 6508-43-6 | C23H26O4 | 366.46 | O=C(CC(C)(C)CC1=O)C1[C@H]2C3=C(CC(C)(C)CC3=O)OC4=CC=CC=C24 |
| EOS-AX7847 | McN-A 343 | 55-45-8 | C14H18Cl2N2O2 | 317.21 | ClC1=CC(NC(OCC#CC[N+](C)(C)C)=O)=CC=C1.[Cl-] |
| EOS-AX7848 | NF 449 | 627034-85-9 | C41H24N6Na8O29S8 | 1505.06 | [O-]/C(C1=CC(/C([O-])=N/C2=C(S(O)(=O)=O)C=C(S([O-])(=O)=O)C=C2)=CC(/N=C([O-])/NC3=CC(/C([O-])=N/C4=C(S(O)(=O)=O)C=C(S([O-])(=O)=O)C=C4)=CC(/C([O-])=N/C5=C(S(O)(=O)=O)C=C(S(O)(=O)=O)C=C5)=C3)=C1)=N\C6=C(S(O)(=O)=O)C=C(S([O-])(=O)=O)C=C6.[Na+].[Na+].[Na+].[ |
| EOS-AX7849 | VDM 11 | 313998-81-1 | C27H39NO2 | 409.61 | O=C(CCC/C=C/C/C=C/C/C=C/C/C=C/CCCCC)NC(C(C)=C1)=CC=C1O |
| EOS-AX7850 | (RS)-3,4-DCPG | 176796-64-8 | C10H9NO6 | 239.18 | OC([C@H](C1=CC=C(C(O)=O)C(C(O)=O)=C1)N)=O |
| EOS-AX7851 | (R)-3,4-DCPG | 201730-10-1 | C10H9NO6 | 239.18 | OC([C@@H](C1=CC=C(C(O)=O)C(C(O)=O)=C1)N)=O |
| EOS-AX7852 | Kenpaullone | 142273-20-9 | C16H11BrN2O | 327.18 | BrC1=CC=C2NC3=C(CC(NC4=CC=CC=C34)=O)C2=C1 |
| EOS-AX7853 | CP 339818 hydrochloride | 478341-55-8 | C21H24N2.HCl | 340.89 | CCCCC/N=C(C1=CC=CC=C12)/C=CN2CC3=CC=CC=C3.Cl |
| EOS-AX7854 | SCH 202676 hydrobromide | 70375-43-8 | C15H13N3S.HBr | 348.26 | C/N=C(S1)\N=C(N1C2=CC=CC=C2)C3=CC=CC=C3.Br |
| EOS-AX7855 | FPL 64176 | 120934-96-5 | C22H21NO3 | 347.41 | O=C(C1=CC=CC=C1CC2=CC=CC=C2)C3=C(C)NC(C)=C3C(OC)=O |
| EOS-AX7856 | (-)-Terreic acid | 121-40-4 | C7H6O4 | 154.12 | O=C(C(C)=C1O)[C@@H]2O[C@@H]2C1=O |
| EOS-AX7857 | YM 022 | 145084-28-2 | C32H28N4O3 | 516.6 | O=C1N(CC(C2=CC=CC=C2C)=O)C3=CC=CC=C3C(C4=CC=CC=C4)=N[C@H]1NC(NC5=CC=CC(C)=C5)=O |
| EOS-AX7858 | CGP 39551 | 127910-32-1 | C8H16NO5P | 237.19 | OP(O)(C/C(C)=C/[C@H](C(OCC)=O)N)=O |
| EOS-AX7859 | SDM25N hydrochloride | 342884-71-3 | C26H26N2O3.HCl | 450.96 | O[C@]([C@@H]1N(CC(C)=C)CC2)(CC3=C4NC5=CC=CC=C35)[C@]2(C6=C(C=C7)C1)[C@H]4OC6=C7O.Cl |
| EOS-AX7860 | Chromanol 293B | 163163-23-3 | C15H20N2O4S | 324.39 | O[C@@H](C(C)(C)OC1=C2C=C(C#N)C=C1)[C@H]2N(C)S(=O)(CC)=O |
| EOS-AX7861 | NAS-181 | 1217474-40-2 | C19H26N2O4.2CH3SO3H | 538.63 | OS(=O)(C)=O.OS(=O)(C)=O.N1(CCOCC1)CC2=CC3=CC=CC(OC[C@@H]4OCCNC4)=C3OC2 |
| EOS-AX7862 | 1400W dihydrochloride | 214358-33-5 | C10H15N3.2HCl | 250.17 | NCC1=CC(C/N=C(C)/N)=CC=C1.Cl.Cl |
| EOS-AX7863 | D-myo-Inositol-1,3,4,5-tetrakisphosphate, octapotassium salt | 145843-69-2 | C6H8O18P4.K8 | 804.73 | O[C@@]1([H])[C@@](OP([O-])([O-])=O)([H])[C@@](O)([H])[C@@](OP([O-])([O-])=O)([H])[C@](OP([O-])([O-])=O)([H])[C@]1([H])OP([O-])([O-])=O.[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+] |
| EOS-AX7864 | MAFP | 188404-10-6 | C21H36FO2P | 370.49 | F[P@](OC)(CCCC/C=C/C/C=C/C/C=C/C/C=C/CCCCC)=O |
| EOS-AX7865 | DCEBIO | 60563-36-2 | C9H8Cl2N2O | 231.08 | ClC(C=C(C(NC1=O)=C2)N1CC)=C2Cl |
| EOS-AX7866 | (S)-(+)-Dimethindene maleate | 136152-65-3 | C20H24N2.C4H4O4 | 408.5 | OC(/C=C\C(O)=O)=O.C[C@H](C1=NC=CC=C1)C2=C(CCN(C)C)CC3=CC=CC=C23 |
| EOS-AX7867 | PPT | 263717-53-9 | C24H22N2O3 | 386.45 | OC1=CC=C(C=C1)C(N(C(C=C2)=CC=C2O)N/3)=C(CCC)C3=C(C=C4)/C=CC4=O |
| EOS-AX7868 | Citalopram hydrobromide | 59729-32-7 | C20H21FN2O.HBr | 405.31 | FC1=CC=C(C=C1)[C@@]2(CCCN(C)C)OCC3=CC(C#N)=CC=C23.Br |
| EOS-AX7869 | DuP 697 | 88149-94-4 | C17H12BrFO2S2 | 411.3 | BrC1=CC(C(C=C2)=CC=C2S(=O)(C)=O)=C(C(C=C3)=CC=C3F)S1 |
| EOS-AX7870 | SQ 22536 | 17318-31-9 | C9H11N5O | 205.22 | NC(N=CN=C12)=C2N=CN1[C@@H]3OCCC3 |
| EOS-AX7871 | MDL 12330A hydrochloride | 40297-09-4 | C23H36N2.HCl | 377.01 | [C@@H](CCC1)(C2=CC=CC=C2)[C@@H]1N/C3=N/CCCCCCCCCCC3.Cl |
| EOS-AX7872 | Ruthenium Red | 11103-72-3 | H42N14O2Ru3Cl6 | 786.35 | [Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].N.N.N.N.N.N.N.N.N.N.N.N.N.N.[O].[O].[Ru+2].[Ru+2].[Ru+2] |
| EOS-AX7873 | BMY 45778 | 152575-66-1 | C26H18N2O5 | 438.44 | OC(COC1=CC(C2=C(C3=NC(C4=CC=CC=C4)=C(C5=CC=CC=C5)O3)N=CO2)=CC=C1)=O |
| EOS-AX7874 | N-Arachidonylglycine | 179113-91-8 | C22H35NO3 | 361.52 | O=C(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)NCC(O)=O |
| EOS-AX7875 | O-2093 | 439080-01-0 | C34H43Cl2NO3 | 584.62 | ClC1=CC(CN(C(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)CC(C=C2Cl)=CC=C2O)=CC=C1O |
| EOS-AX7876 | SKF 81297 hydrobromide | 67287-39-2 | C16H16ClNO2.HBr | 370.67 | ClC1=C2C([C@@H](C3=CC=CC=C3)CNCC2)=CC(O)=C1O.Br |
| EOS-AX7877 | GYKI 52466 dihydrochloride | 102771-26-6 | C17H15N3O2.2HCl | 366.24 | CC(CC1=CC(OCO2)=C2C=C13)=NN=C3C4=CC=C(N)C=C4 |
| EOS-AX7878 | SU 4312 | 5812-07-7 | C17H16N2O | 264.33 | O=C1NC2=CC=CC=C2/C1=C\C(C=C3)=CC=C3N(C)C |
| EOS-AX7879 | PACOCF3 | 141022-99-3 | C17H31F3O | 308.43 | FC(F)(C(CCCCCCCCCCCCCCC)=O)F |
| EOS-AX7880 | AACOCF3 | 149301-79-1 | C21H31F3O | 356.47 | FC(F)(C(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)F |
| EOS-AX7881 | Ghrelin (human) | 258279-04-8 | C149H249N47O42 | 3370.9 | |
| EOS-AX7882 | PPAHV | 175796-50-6 | C39H44O11 | 688.77 | O[C@@]1([C@H](C=C(C)C2=O)[C@]32O)[C@@H](C=C(COC(CC(C=C4OC)=CC=C4O)=O)C3)[C@H](C5(C)C)[C@]5([C@H]([C@H]1C)OC(CC6=CC=CC=C6)=O)OC(C)=O |
| EOS-AX7883 | CGP 37849 | 127910-31-0 | C6H12NO5P | 209.14 | C/C(CP(O)(O)=O)=C([H])\C(N)C(O)=O |
| EOS-AX7884 | Suramin hexasodium salt | 129-46-4 | C51H34N6Na6O23S6 | 1429.15 | [O-]S(=O)(C1=C(C(NC(C2=CC=C(C)C(NC(C3=CC=CC(NC(NC4=CC(C(NC5=CC(C(NC(C(C6=CC(S([O-])(=O)=O)=C7)=C7S([O-])(=O)=O)=CC=C6S([O-])(=O)=O)=O)=CC=C5C)=O)=CC=C4)=O)=C3)=O)=C2)=O)=CC=C8S([O-])(=O)=O)C8=CC(S([O-])(=O)=O)=C1)=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] |
| EOS-AX7885 | (-)-[3R,4S]-Chromanol 293B | 163163-24-4 | C15H20N2O4S | 324.39 | O[C@@H](C(C)(C)OC1=C2C=C(C#N)C=C1)[C@H]2N(C)S(=O)(CC)=O |
| EOS-AX7886 | GR 127935 hydrochloride | 148642-42-6 | C29H31N5O3.HCl | 534.06 | O=C(C(C=C1)=CC=C1C2=CC=C(C3=NOC(C)=N3)C=C2C)NC4=CC=C(C(N5CCN(C)CC5)=C4)OC.Cl |
| EOS-AX7887 | FIT | 85951-63-9 | C23H27N3OS | 393.55 | S=C=NC1=CC=C(C=C1)CCN2CCC(CC2)N(C(CC)=O)C3=CC=CC=C3 |
| EOS-AX7888 | D-myo-Inositol 1,4,5-trisphosphate, hexapotassium salt | 103476-24-0 | C6H9O15P3.K6 | 648.64 | O[C@H]([C@H]([C@@H]1O)OP([O-])([O-])=O)[C@H]([C@H]([C@H]1O)OP([O-])([O-])=O)OP([O-])([O-])=O.[K+].[K+].[K+].[K+].[K+].[K+] |
| EOS-AX7889 | GR 89696 fumarate | 126766-32-3 | C19H25Cl2N3O3.C4H4O4 | 530.4 | ClC1=CC(CC(N2[C@H](CN(C(OC)=O)CC2)CN3CCCC3)=O)=CC=C1Cl.OC(/C=C/C(O)=O)=O |
| EOS-AX7890 | Oleylethanolamide | 111-58-0 | C20H39NO2 | 325.53 | O=C(CCCCCCC/C=C/CCCCCCCC)NCCO |
| EOS-AX7891 | DEA | 150314-35-5 | C24H41NO2 | 375.59 | |
| EOS-AX7892 | GR 231118 | 158859-98-4 | C110H170N34O24 | 2352.77 | |
| EOS-AX7893 | MNI-caged-L-glutamate | 295325-62-1 | C14H17N3O6 | 323.3 | O=C(CC[C@@H](C(O)=O)N)N(C1=C(C=C2)[N+]([O-])=O)CCC1=C2OC |
| EOS-AX7894 | CGP 78608 hydrochloride | 206648-13-7 | C11H13BrN3O5P.HCl | 414.58 | C[C@@](P(O)(O)=O)([H])NCC1=CC(Br)=CC(N2)=C1NC(C2=O)=O.Cl |
| EOS-AX7895 | DPN | 1428-67-7 | C15H13NO2 | 239.27 | OC1=CC=C(C=C1)[C@H](C#N)CC(C=C2)=CC=C2O |
| EOS-AX7896 | Combretastatin A4 | 117048-59-6 | C18H20O5 | 316.35 | OC1=CC(/C=C\C2=CC(OC)=C(C(OC)=C2)OC)=CC=C1OC |
| EOS-AX7897 | Rimcazole dihydrochloride | 75859-03-9 | C21H27N3.2HCl | 394.39 | C[C@@H]1N[C@H](C)CN(CCCN2C3=CC=CC=C3C4=CC=CC=C24)C1.Cl.Cl |
| EOS-AX7898 | CL 316243 disodium salt | 151126-84-0 | C20H18ClNNa2O7 | 465.8 | ClC1=CC([C@@H](CN[C@@H](C)CC2=CC=C3OC(C([O-])=O)(C([O-])=O)OC3=C2)O)=CC=C1.[Na+].[Na+] |
| EOS-AX7899 | FR 122047 hydrochloride | 130717-51-0 | C23H25N3O3S.HCl | 459.99 | O=C(C1=NC(C(C=C2)=CC=C2OC)=C(C(C=C3)=CC=C3OC)S1)N4CCN(C)CC4.Cl |
| EOS-AX7900 | TMS | 24144-92-1 | C18H20O4 | 300.35 | COC1=CC(OC)=CC=C1/C=C/C2=CC(OC)=CC(OC)=C2 |
| EOS-AX7901 | SR 59230A hydrochloride | 1135278-41-9 | C21H27NO2.HCl | 361.91 | O[C@H](COC1=CC=CC=C1CC)CN[C@H]2CCCC3=CC=CC=C23.Cl |
| EOS-AX7902 | SB 205384 | 160296-13-9 | C17H18N2O3S | 330.4 | O[C@H](C1)CCC2=C1SC3=NC(C)=C(C(OCC#CC)=O)C(N)=C23 |
| EOS-AX7903 | CGP 7930 | 57717-80-3 | C19H32O2 | 292.46 | CC(C)(C1=C(O)C(C(C)(C)C)=CC(CC(C)(CO)C)=C1)C |
| EOS-AX7904 | CGP 13501 | 56189-68-5 | C19H30O2 | 290.44 | CC(C)(C1=C(O)C(C(C)(C)C)=CC(CC(C)(C=O)C)=C1)C |
| EOS-AX7905 | SDZ 21009 | 39731-05-0 | C19H28N2O4 | 348.44 | O[C@@H](COC1=C2C(NC(C(OC(C)C)=O)=C2)=CC=C1)CNC(C)(C)C |
| EOS-AX7906 | 5-Iodo-A-85380 dihydrochloride | 1217837-17-6 | C9H11IN2O.2HCl | 363.03 | IC1=CC(OC[C@]2([H])CCN2)=CN=C1.Cl.Cl |
| EOS-AX7907 | Quinelorane hydrochloride | 97548-97-5 | C14H22N4.2HCl | 319.27 | NC1=NC=C2C[C@H]3N(CCC)CCC[C@H]3CC2=N1.Cl.Cl |
| EOS-AX7908 | LY 215840 | 137328-52-0 | C24H33N3O2 | 395.54 | O=C([C@@H]1C[C@@H]2[C@@H](CC3=CN(C(C)C)C4=CC=CC2=C34)N(C)C1)N[C@@H](CCC5)[C@@H]5O |
| EOS-AX7909 | 5-Iodo-A-85380, 5-trimethylstannyl N-BOC derivative | 213766-21-3 | C17H28N2O3Sn | 427.11 | O=C(N1[C@H](COC2=CN=CC([Sn](C)(C)C)=C2)CC1)OC(C)(C)C |
| EOS-AX7910 | SNC 162 | 178803-51-5 | C27H37N3O | 419.61 | C=CCN([C@](CN1[C@@](C2=CC=C(C(N(CC)CC)=O)C=C2)([H])C3=CC=CC=C3)([H])C)C[C@]1([H])C |
| EOS-AX7911 | A 68930 hydrochloride | 130465-39-3 | C16H17NO3.HCl | 307.78 | OC(C1=C(C=C2)[C@H](CN)O[C@H](C3=CC=CC=C3)C1)=C2O.Cl |
| EOS-AX7912 | DCPIB | 82749-70-0 | C22H28Cl2O4 | 427.37 | ClC1=C2C([C@@](CC2=CC(OCCCC(O)=O)=C1Cl)(CCCC)C3CCCC3)=O |
| EOS-AX7913 | (S)-CPW 399 | 389888-02-2 | C10H13N3O4 | 239.23 | O=C1NC(N(C[C@@H](C(O)=O)N)C2=C1CCC2)=O |
| EOS-AX7914 | (R)-(+)-Bay K 8644 | 98791-67-4 | C16H15F3N2O4 | 356.3 | FC(F)(C1=CC=CC=C1[C@@H]2C(C(OC)=O)=C(C)NC(C)=C2[N+]([O-])=O)F |
| EOS-AX7915 | (S)-(-)-Bay K 8644 | 98625-26-4 | C16H15F3N2O4 | 356.3 | FC(F)(C1=CC=CC=C1[C@H]2C(C(OC)=O)=C(C)NC(C)=C2[N+]([O-])=O)F |
| EOS-AX7916 | NSC 95397 | 93718-83-3 | C14H14O4S2 | 310.38 | O=C1C2=CC=CC=C2C(C(SCCO)=C1SCCO)=O |
| EOS-AX7917 | CD 437 | 125316-60-1 | C27H26O3 | 398.5 | OC1=CC=C(C2=CC=C3C(C=CC(C(O)=O)=C3)=C2)C=C1[C@]4(C[C@@H]5C6)C[C@@H]6C[C@H](C5)C4 |
| EOS-AX7918 | SC 560 | 188817-13-2 | C17H12ClF3N2O | 352.74 | ClC1=CC=C(C=C1)C2=CC(C(F)(F)F)=NN2C(C=C3)=CC=C3OC |
| EOS-AX7919 | STO-609 acetate | 1173022-21-3 | C19H10N2O3.C2H4O2 | 374.35 | O=C1N2C(C3=CC=C(C(O)=O)C4=CC=CC1=C34)=NC5=CC=CC=C25.OC(C)=O |
| EOS-AX7920 | AG 825 | 149092-50-2 | C19H15N3O3S2 | 397.47 | OC(C(CSC1=NC2=CC=CC=C2S1)=CC(/C=C(C#N)/C(N)=O)=C3)=C3OC |
| EOS-AX7921 | 6'-Iodoresiniferatoxin | 335151-55-8 | C37H39IO9 | 754.6 | IC(C=C(C=C1OC)CC(OCC2=C[C@@H]3[C@]([C@H](C)C4)([C@H](C=C(C)C5=O)[C@@]5(C2)O)O[C@]6(CC7=CC=CC=C7)O[C@H]3[C@@]4(C(C)=C)O6)=O)=C1O |
| EOS-AX7922 | Tracazolate hydrochloride | 1135210-68-2 | C16H24N4O2.HCl | 340.85 | O=C(C1=C(C)N=C2N(CC)N=CC2=C1NCCCC)OCC.Cl |
| EOS-AX7923 | Roxindole hydrochloride | 108050-82-4 | C23H26N2O.HCl | 382.93 | OC1=CC=C2NC=C(C2=C1)CCCCN3CCC(C4=CC=CC=C4)=CC3.Cl |
| EOS-AX7924 | (S)-SNAP 5114 | 157604-55-2 | C30H35NO6 | 505.61 | OC([C@@H]1CN(CCOC(C(C=C2)=CC=C2OC)(C(C=C3)=CC=C3OC)C(C=C4)=CC=C4OC)CCC1)=O |
| EOS-AX7925 | Virodhamine | 287937-12-6 | C22H37NO2 | 347.54 | |
| EOS-AX7926 | HEMADO | 403842-38-6 | C17H23N5O4 | 361.4 | O[C@H]1[C@@H](N2C3=NC(C#CCCCC)=NC(NC)=C3N=C2)O[C@H](CO)[C@H]1O |
| EOS-AX7927 | Neurokinin B (human, porcine) | 86933-75-7 | C55H79N13O14S2 | 1210.43 | |
| EOS-AX7928 | MRS 1706 | 264622-53-9 | C27H29N5O5 | 503.56 | CCCN(C1=O)C2=C(NC(C3=CC=C(OCC(NC4=CC=C(C(C)=O)C=C4)=O)C=C3)=N2)C(N1CCC)=O |
| EOS-AX7929 | SKF 83566 hydrobromide | 108179-91-5 | C17H18BrNO.HBr | 413.15 | CN1CCC2=CC(Br)=C(O)C=C2C(C3=CC=CC=C3)C1.Br |
| EOS-AX7930 | Ro 32-0432 hydrochloride | 151342-35-7 | C28H28N4O2.HCl | 489.01 | O=C(C(C1=C2N(C3=CC=CC=C13)CC[C@@H](CN(C)C)C2)=C4C5=CN(C)C6=CC=CC=C56)NC4=O.Cl |
| EOS-AX7931 | Indatraline hydrochloride | 96850-13-4 | C16H15Cl2N.HCl | 328.67 | ClC1=CC([C@@H](C2=CC=CC=C32)C[C@H]3NC)=CC=C1Cl.Cl |
| EOS-AX7932 | NBI 27914 hydrochloride | 1215766-76-9 | C18H20Cl4N4.HCl | 470.66 | CCCN(C1=NC(C)=NC(NC2=C(Cl)C=C(Cl)C=C2Cl)=C1Cl)CC3CC3.Cl |
| EOS-AX7933 | SCH 79797 dihydrochloride | 1216720-69-2 | C23H25N5.2HCl | 444.41 | CC(C1=CC=C(CN2C=CC3=C2C=CC(N/C4=N/C5CC5)=C3C(N4)=N)C=C1)C.Cl.Cl |
| EOS-AX7934 | NKH 477 | 138605-00-2 | C27H43NO8.HCl | 546.1 | O[C@]1([C@]([C@H]2OC(C)=O)(C)O[C@@](C)(C=C)CC1=O)[C@]3(C)[C@@H]([C@@H]2OC(CCN(C)C)=O)C(C)(C)CC[C@@H]3O.Cl |
| EOS-AX7935 | Rottlerin | 82-08-6 | C30H28O8 | 516.55 | OC1=C2C(OC(C)(C)C=C2)=C(C(/C=C\C3=CC=CC=C3)=O)C(O)=C1CC(C(O)=C(C)C(O)=C4C(C)=O)=C4O |
| EOS-AX7936 | SB 366791 | 472981-92-3 | C16H14ClNO2 | 287.75 | ClC1=CC=C(C=C1)/C=C/C(NC2=CC=CC(OC)=C2)=O |
| EOS-AX7937 | Remacemide hydrochloride | 111686-79-4 | C17H20N2O.HCl | 304.82 | O=C(CN)N[C@](C1=CC=CC=C1)(C)CC2=CC=CC=C2.Cl |
| EOS-AX7938 | DFB | 15332-10-2 | C14H10F2N2 | 244.24 | FC1=CC(/C=N\N=C/C2=CC=CC(F)=C2)=CC=C1 |
| EOS-AX7939 | Calphostin C | 121263-19-2 | C44H38O14 | 790.76 | OC1=C2C3=C(C(C[C@@H](C)OC(C4=CC=CC=C4)=O)=C1OC)C(C(C[C@@H](C)OC(OC(C=C5)=CC=C5O)=O)=C6OC)=C(C7=C6O)C(C(OC)=CC7=O)=C3C(OC)=CC2=O |
| EOS-AX7940 | Herbimycin A | 70563-58-5 | C30H42N2O9 | 574.67 | O=C(C(NC1=O)=C2)C([C@@H]([C@@H](C)C[C@@H]([C@@H]([C@@H](C)/C=C(C)/[C@@H]([C@H](/C=C/C=C1/C)OC)OC(N)=O)OC)OC)OC)=CC2=O |
| EOS-AX7941 | MEN 10376 | 135306-85-3 | C57H68N12O10 | 1081.24 | O=C([C@@H](C(C)C)NC([C@@H](CC1=CNC2=CC=CC=C12)NC([C@H](CC(C=C3)=CC=C3O)NC([C@H](CC(O)=O)N)=O)=O)=O)N[C@H](C(N[C@H](C(N[C@@H](C(N)=O)CCCCN)=O)CC4=CNC5=CC=CC=C45)=O)CC6=CNC7=CC=CC=C67 |
| EOS-AX7942 | RP 67580 | 135911-02-3 | C29H30N2O2 | 438.57 | O=C1[C@@H]2[C@@H](CN(C(CC3=CC=CC=C3OC)=N)C2)C(C4=CC=CC=C4)(C5=CC=CC=C5)CC1 |
| EOS-AX7943 | IEM 1460 | 121034-89-7 | C19H37N2Br.HBr | 454.33 | C[N+](C)(C)CCCCCNC[C@]1(C[C@@H]2C3)C[C@@H]3C[C@H](C2)C1.Br.[Br-] |
| EOS-AX7944 | U 18666A | 3039-71-2 | C25H41NO2.HCl | 424.07 | O=C1[C@]2(C)[C@@H](CC1)[C@H]3[C@H](CC2)[C@](CC[C@@H]4OCCN(CC)CC)(C)C(C4)=CC3.Cl |
| EOS-AX7945 | [bAla8]-Neurokinin A(4-10) | 122063-01-8 | C35H56N8O10S | 780.93 | O=C([C@H](C(C)C)NC([C@@H](CC1=CC=CC=C1)NC([C@H](CO)NC([C@H](CC(O)=O)N)=O)=O)=O)NCCC(N[C@@H](C(N[C@H](C(N)=O)CCSC)=O)CC(C)C)=O |
| EOS-AX7946 | OLDA | 105955-11-1 | C26H43NO3 | 417.63 | O=C(CCCCCCC/C=C/CCCCCCCC)NCCC(C=C1O)=CC=C1O |
| EOS-AX7947 | Mesulergine hydrochloride | 72786-12-0 | C18H26N4O2S.HCl | 398.95 | O=S(N[C@H]1C[C@H]2[C@@H](CC3=CN(C)C4=CC=CC2=C34)N(C)C1)(N(C)C)=O.Cl |
| EOS-AX7948 | 8-CPT-2Me-cAMP, sodium salt | 510774-50-2 | C17H16ClN5O6PS.Na | 507.82 | CO[C@]([C@]1([H])N2C3=NC=NC(N)=C3N=C2SC4=CC=C(Cl)C=C4)([H])[C@@](O5)([H])[C@@](O1)([H])COP5([O-])=O.[Na+] |
| EOS-AX7949 | Apamin | 24345-16-2 | C79H131N31O24S4 | 2027.34 | |
| EOS-AX7950 | GR 125487 sulfamate | 859502-43-5 | C19H26FN3O5S.H2NSO3H | 524.58 | COC1=C(C(OCC2CCN(CCNS(C)(=O)=O)CC2)=O)C3=C(N1)C=CC(F)=C3.NS(O)(=O)=O |
| EOS-AX7951 | SB 206553 hydrochloride | 1197334-04-5 | C17H16N4O.HCl | 328.8 | CN1C=CC2=CC3=C(C=C21)CCN3/C(O)=N/C4=CN=CC=C4 |
| EOS-AX7952 | SKF 77434 hydrobromide | 300561-58-4 | C19H21NO2.HBr | 376.29 | OC(C=C1[C@@H](C2=CC=CC=C2)CN(CC=C)CCC1=C3)=C3O.Br |
| EOS-AX7953 | PD 102807 | 23062-91-1 | C23H24N2O4 | 392.45 | O=C(C1=C(C)NC2=C1C3=C(C=C2)O[C@@H]4N(CCC5=C4C=CC(OC)=C5)C3)OCC |
| EOS-AX7954 | RU 28318, potassium salt | 76676-34-1 | C25H37O4K | 440.66 | CCC[C@]([C@]12[H])([H])CC3=CC(CC[C@@]3([C@@]1([H])CC[C@]4([C@@]2([H])CC[C@@]4(O)CCC([O-])=O)C)C)=O.[K+] |
| EOS-AX7955 | Cl-HIBO | 909400-43-7 | C6H7ClN2O4 | 206.59 | ClC1=C(C[C@@H](C(O)=O)N)ONC1=O |
| EOS-AX7956 | LE 300 | 274694-98-3 | C20H22N2 | 290.41 | CN1CCC2=C(CC3=CC=CC=C3CC1)NC4=CC=CC=C24 |
| EOS-AX7957 | YM 90709 | 163769-88-8 | C22H21N3O2 | 359.43 | CC(CC1=CC(OC)=C2OC)(C)N3C(C1=C2)=CC4=NC5=CC=CC=C5N=C34 |
| EOS-AX7958 | GW 7647 | 265129-71-3 | C29H46N2O3S | 502.75 | O=C(N(CCC(C=C1)=CC=C1SC(C)(C(O)=O)C)CCCCC2CCCCC2)NC3CCCCC3 |
| EOS-AX7959 | PIT | 56583-49-4 | C13H8N2O2.C7H8O3S | 396.42 | OS(=O)(C1=CC=C(C)C=C1)=O.[O-][N+](C2=CC=CC=C23)=C(C4=NC=CC=C4)C3=O |
| EOS-AX7960 | K 252a | 99533-80-9 | C27H21N3O5 | 467.48 | O[C@](C1)(C(OC)=O)[C@@]2(C)O[C@@H]1N3C4=C5N2C6=CC=CC=C6C5=C(CNC7=O)C7=C4C8=CC=CC=C38 |
| EOS-AX7961 | Autocamtide-2-related inhibitory peptide | 167114-91-2 | C78 H142 N22 O20 . C2 H F3 O2 | 1822.12 | CCCCCCCCCCCCC/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=O)([H])CC(C)C)([H])C)([H])CC(O)=O)([H])C(C)C)([H])C)([H |
| EOS-AX7962 | SCH 28080 | 76081-98-6 | C17H15N3O | 277.33 | N#CCC1=C(C)N=C2N1C=CC=C2OCC3=CC=CC=C3 |
EOS Med Chem, Medicinal Chemical is Big is China TOP 100 CRO comapny, mainly in Med-chemicals, Custom synthesis. We have GMP, ISO plant plant serving you.
搜索此博客
2017年8月2日星期三
2017.8.3 list 15
订阅:
评论 (Atom)